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ABSTRACT 
 
Toxicity Analysis of Polycyclic Aromatic Hydrocarbon Mixtures. (May 2009) 
Christine Sue Naspinski, B.S., Pennsylvania State University 
Co-Chairs of Advisory Committee: Dr. Kirby C. Donnelly 
       Dr. Thomas J. McDonald 
 
Polycyclic aromatic hydrocarbons (PAHs) are widely distributed in the 
environment and are generated by many sources.  Though the potential of PAH-rich 
mixtures to cause health effects has been known for almost a century, there are still 
unanswered questions about the levels of PAHs in the environment, the potential for 
human exposure to PAHs, the health effects associated with exposure, and how genetic 
susceptibility influences the extent of health effects in individuals. 
The first objective of this research was to quantify concentrations of PAHs in 
samples of settled house dust collected from homes in Azerbaijan, China, and Texas.  
The trends of PAH surface loadings and percentage of carcinogenic PAHs were China 
> Azerbaijan > Texas, indicating that the risk of health effects from exposure to PAHs in 
house dust is highest in the Chinese population and lowest in the Texas population.  
PAHs in China and Azerbaijan were derived mainly from combustion sources; Texas 
PAHs were derived from unburned fossil fuels such as petroleum. 
The second objective of this research was to investigate the effect of pregnane 
X receptor (PXR) on the genotoxicity of benzo[a]pyrene (BaP).  BaP treatment resulted 
in significantly lower DNA adduct levels in PXR-transfected HepG2 cells than in 
parental HepG2 cells.  Total GST enzymatic activity and mRNA levels of several 
metabolizing enyzmes were significantly higher in cells overexpressing PXR.  These 
results suggest that PXR protects cells against DNA damage by PAHs such as BaP, 
possibly through a coordinated regulation of genes involved in xenobiotic metabolism. 
The third objective of this research was to investigate biomarkers of exposure in 
house mice (Mus musculus) exposed to PAH mixtures in situ.  Mice and soil were 
collected near homes in Sumgayit and Khizi, Azerbaijan.  Mean liver adduct levels were 
significantly higher in Khizi than in Sumgayit.  Mean lung and kidney adduct levels were 
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similar in the two regions.  The DNA lesions detected may be a combination of 
environmentally-induced DNA adducts and naturally-occurring I-compounds.  PAHs 
were present at background levels in soils from both Khizi and Sumgayit.  It appears 
that health risks posed to rodents by soil-borne PAHs are low in these two areas. 
 
 v 
ACKNOWLEDGMENTS 
 
I would like to thank my committee co-chairs Drs. K.C. Donnelly and Thomas 
McDonald, committee members Drs. Robin Autenrieth and Yanan Tian, and former 
committee member Dr. John Bickham, for their support and guidance throughout my 
graduate studies.  Each taught me about many aspects of science, research, and life in 
academia.  I would also like to thank Dr. Guo Dong Zhou for his significant contribution 
to my scientific training, for thorough reviews of manuscripts and for continued 
encouragement. 
The research presented in this dissertation is the result of the efforts of many 
people.  I would like to acknowledge and thank them for their efforts.  The collection of 
dust samples was coordinated by Dr. Leslie Cizmas, Dr. Ziad Naufal and Rebecca 
Lingenfelter in Texas, China, and Azerbaijan, respectively.  Soil and mouse samples 
were collected from Azerbaijan by Dr. John Bickham and Dr. Cole Matson.  Dust and 
soil samples were extracted by Dr. Ling Yu He and analyzed by Dr. Thomas McDonald.  
Mice were dissected and tissues processed and postlabeled by Dr. Guo Dong Zhou, 
Shirley Wang, and Rebecca Lingenfelter.  The hPXR-enhanced HepG2 cell line was 
developed and maintained by Dr. Xinsheng Gu.  The GST assay was performed by Dr. 
Susanne Mertens-Talcott and members of her lab.  Postlabeling of HepG2 cell DNA 
was supervised by Dr. Guo Dong Zhou and assisted by Molly Richardson.  Support for 
real-time RT-PCR was provided by Dr. Laurie Davidson.  Also, I would like to thank the 
National Institute of Environmental Health Sciences (NIEHS) and the Environmental 
Protection Agency for funding this research, and to thank NIEHS and TAMU for funding 
my graduate education. 
I would like to thank the faculty and staff of Toxicology, SRPH and VIBS for 
support.  Special thanks go to Nancy White, Kim Daniel, Britta Wright and Michelle 
Bosenbark for friendship, guidance, and assistance with the administrative aspects of 
graduate studies.  I thank my friends and fellow students who provided friendship, 
training, advice and encouragement.  These include Dr. Leslie Cizmas, Dr. Ling Yu He, 
Dr. Annika Gillespie, Rebecca Lingenfelter, Matt Kelley, Dr. Tracie Phillips, Dr. Ziad 
Naufal, Molly Richardson, Shirley Wang, Dr. Xinsheng Gu, Sui Ke, Dr. Liu Duan, Ying 
 vi 
Xie, Dr. Cole Matson, Dr. Petros Dimitriou-Christidis, Dr. Erica Bruce, Dr. Henry 
Huebner, and Dr. Evans Afriyie-Gyawu. 
Finally, I would like to thank my family for their support and encouragement.  
Special thanks go to my husband, Ed, for persevering during the last five years.  I would 
never have made it without his love, support, advice and sense of humor. 
 vii 
TABLE OF CONTENTS 
 
  Page 
 
ABSTRACT .............................................................................................................. iii 
ACKNOWLEDGMENTS ........................................................................................... v 
TABLE OF CONTENTS............................................................................................ vii 
LIST OF FIGURES ................................................................................................... ix 
LIST OF TABLES ..................................................................................................... x 
NOMENCLATURE.................................................................................................... xi 
CHAPTER 
I INTRODUCTION........................................................................................... 1 
  1.1 Overview......................................................................................... 1 
  1.2 Environmental Mixtures and Human Health .................................... 1 
   1.2.1 Exposure to Environmental Mixtures ................................... 1 
   1.2.2 Health Effects of Environmental Mixtures ............................ 5 
   1.2.3 Genetic Susceptibility .......................................................... 12 
  1.3 Polycyclic Aromatic Hydrocarbons.................................................. 15 
   1.3.1 Chemical Structure and Properties...................................... 15 
   1.3.2 Sources............................................................................... 18 
   1.3.3 Environmental Distribution................................................... 20 
   1.3.4 Health Effects...................................................................... 21 
  1.4 Analysis of Environmental Mixtures ................................................ 36 
   1.4.1 Chemical Analysis ............................................................... 36 
   1.4.2 Mammalian Cell Culture ...................................................... 38 
   1.4.3 Laboratory Animals ............................................................. 41 
   1.4.4 Animals in situ ..................................................................... 43 
  1.5 Objectives....................................................................................... 48 
II A COMPARISON OF CONCENTRATIONS OF PAHS DETECTED IN DUST 
FROM VARIOUS REGIONS OF THE WORLD ............................................. 51 
  2.1 Introduction..................................................................................... 51 
  2.2 Materials and Methods.................................................................... 52 
   2.2.1 Sampling Sites .................................................................... 52 
   2.2.2 Dust Sample Collection ....................................................... 54 
   2.2.3 Sample Extraction and Analysis .......................................... 54 
  2.3 Results ........................................................................................... 55 
   2.3.1 PAH Surface Loadings ........................................................ 55 
   2.3.2 PAH Profile ......................................................................... 60 
   2.3.3 Source Classification........................................................... 61 
  2.4 Discussion ...................................................................................... 63 
 
 viii 
CHAPTER Page 
 
III THE ROLE OF PREGNANE X RECEPTOR IN BAP-INDUCED DNA 
DAMAGE IN HEPG2 CELLS......................................................................... 67 
 3.1 Introduction..................................................................................... 67 
 3.2 Materials and Methods.................................................................... 68 
   3.2.1 Materials ............................................................................. 68 
   3.2.2 Stable Transfection ............................................................. 68 
   3.2.3 Cell Culture and Treatment ................................................. 69 
   3.2.4 DNA Adduct Assay.............................................................. 69 
   3.2.5 Real-time Quantitative RT-PCR........................................... 71 
   3.2.6 GST Assay.......................................................................... 71 
 3.3 Results ........................................................................................... 71 
   3.3.1 Establishment of Stable Transfected Cell Line .................... 71 
   3.3.2 PXR Impact on BaP-induced DNA Adduct Formation.......... 72 
   3.3.3 PXR Regulation of Xenobiotic Metabolism and Elimination 
Genes ................................................................................. 76 
   3.3.4 Effect of PXR on GST Enzymatic Activity ............................ 76 
 3.4 Discussion ...................................................................................... 77 
IV MEASUREMENT OF DNA ADDUCT LEVELS IN MICE EXPOSED TO PAH 
MIXTURES IN SITU ...................................................................................... 82 
 4.1 Introduction..................................................................................... 82 
   4.1.1 Polycyclic Aromatic Hydrocarbons ...................................... 82 
   4.1.2 Exposure Assessment and Biomarkers ............................... 82 
   4.1.3 Study Location: Azerbaijan.................................................. 83 
   4.1.4 Study Objectives ................................................................. 83 
 4.2 Materials and Methods.................................................................... 83 
   4.2.1 Study Sites.......................................................................... 83 
   4.2.2 Mouse Collection................................................................. 84 
   4.2.3 DNA Isolation and Adduct Analysis ..................................... 85 
   4.2.4 Soil Collection ..................................................................... 86 
   4.2.5 Soil Extraction and Analysis ................................................ 86 
 4.3 Results ........................................................................................... 87 
   4.3.1 Mouse DNA Adduct Levels.................................................. 87 
   4.3.2 Soil PAH Levels .................................................................. 90 
 4.4 Discussion ...................................................................................... 92 
V SUMMARY.................................................................................................... 96 
REFERENCES .........................................................................................................100 
VITA .........................................................................................................................119 
 
 
 
 ix 
LIST OF FIGURES 
 
FIGURE Page 
1-1 Environmental exposure model .................................................................. 2 
1-2 Cellular model of xenobiotic fate and toxicity .............................................. 9 
1-3 Exposure-effect relationship ....................................................................... 13 
1-4 Chemical structures of representative PAHs .............................................. 16 
1-5 BaP metabolic pathways ............................................................................ 32 
1-6 Representative PAHs with bay regions....................................................... 33 
1-7 Bioactivation of BaP by bay region dihydrodiol epoxide 
 metabolic pathway...................................................................................... 34 
1-8 Bioactivation of PAH by o-quinone pathway ............................................... 35 
2-1 Variability of floor surface total PAH loadings in each location.................... 58 
2-2 Seasonal variation in floor wipe samples from Azerbaijan and China ......... 59 
2-3 PAH profile by number of aromatic rings in floor wipes from each location. 60 
2-4 Percentage of alkylated analytes................................................................ 61 
3-1 Establishment of stable cell line expressing hPXR ..................................... 70 
3-2 Autoradiographic profiles of DNA adducts in parental HepG2 and  
 hPXR-enhanced cells treated with BaP ...................................................... 72 
3-3 Comparison of levels of DNA adducts in parental HepG2 cells and 
 hPXR-enhanced cells treated with BaP ...................................................... 73 
3-4 Effect of hPXR expression on BaP-DNA adduct formation ......................... 74 
3-5 Effect of hPXR expression on total GST enzymatic activity ........................ 77 
3-6 PXR-regulated detoxification of BaP: a possible metabolic mechanism...... 80 
4-1 Adduct levels detected in mice from locations in Sumgayit and Khizi ......... 88 
4-2 Comparison of tissue adduct levels in individual mice ................................ 89 
 
 x 
LIST OF TABLES 
 
TABLE Page 
1-1 Toxicokinetic processes ............................................................................. 4 
1-2 Toxic equivalency factors for carcinogenic PAHs ....................................... 24 
2-1 Individual PAH analytes quantified in house dust extracts .......................... 56 
2-2 Concentration of total and high molecular weight PAHs detected in 
 dust samples collected from houses in Azerbaijan, China or Texas ........... 57 
2-3 Classification of major PAH sources in dust based on alkyl PAH profile ..... 63 
3-1 Effects of transfected PXR and BaP treatment on gene expression ........... 75 
4-1 Description of wild house mice collected in Azerbaijan............................... 85 
4-2 DNA adduct levels detected in tissues of wild house mice.......................... 88 
4-3 PAH levels in extracts of soil samples collected from sites in Azerbaijan.... 91 
4-4 PAH concentrations in soils of several European countries ........................ 95 
 xi 
NOMENCLATURE 
 
AhR Aryl hydrocarbon receptor 
ATSDR Agency for Toxic Substances and Disease Registry 
BaA Benz[a]anthracene 
BaP Benzo[a]pyrene 
BbF Benzo[b]fluoranthene 
BkF Benzo[k]fluoranthene 
Chr Chrysene 
DBA Dibenz[a,h]anthracene 
ETS Environmental tobacco smoke 
GC/MS Gas chromatography / mass spectrometry 
GST Glutathione S-transferase 
HMW High molecular weight 
hPXR Human PXR 
IDP Indeno[1,2,3-cd]pyrene 
IRIS Integrated risk information system 
LMW Low molecular weight 
PAH Polycyclic aromatic hydrocarbon 
PCB Polychlorinated biphenyl 
PCDD Polychlorinated dibenzo-p-dioxin 
PXR Pregnane X receptor 
RIF Rifampicin 
ROS Reactive oxygen species 
SULT Sulfotransferase 
TCDD 2,3,7,8-Tetrachlorodibenzo-p-dioxin 
TEF Toxic equivalency factor 
TLC Thin-layer chromatography 
UGT UDP glucuronosyl transferase 
USEPA United States Environmental Protection Agency 
 
 1 
CHAPTER I 
INTRODUCTION 
 
1.1 Overview 
Humans are continuously exposed to complex mixtures of chemicals in their 
environments.  Some chemical mixtures can have adverse effects on human health, 
ranging from acute, reversible effects to permanent disability and death.  Complex 
chemical mixtures in the environment may contain tens, hundreds, or even thousands 
of individual compounds.  Evaluating the risk to human health posed by environmental 
mixtures is challenging for many reasons, including: 1) mixture composition is often not 
known, 2) composition and concentration may have large temporal and spatial 
variability, 3) human exposure to mixtures is difficult to assess, 4) toxicity data usually 
are for individual compounds rather than mixtures, 5) toxicity data are often from cell 
culture or laboratory animals rather than humans, 6) toxicity is often evaluated for short-
term high doses, rather than the long-term low doses typical of environmental exposure, 
and 7) individual characteristics of humans can greatly influence susceptibility to health 
effects.  This dissertation describes research designed to address some of these 
challenges for mixtures of polycyclic aromatic hydrocarbons (PAHs), which are 
prevalent environmental contaminants. 
 
1.2 Environmental Mixtures and Human Health 
1.2.1 Exposure to Environmental Mixtures 
Complex mixtures of chemical contaminants exist everywhere in the 
environment, generated by a large number of diverse sources.  Contaminant mixtures 
are present in all environmental media, including outdoor and indoor air, surface and 
ground waters, dust, soils, sediments, and biota.  However, the presence of chemical 
mixtures in the environment does not necessarily lead to a human exposure.  Several 
processes occur between the origin of the mixture and the exposure of a human or 
ecological receptor.  A mixture is generated by a source, released into the environment, 
undergoes transport and/or transformation, and ultimately reaches the receptor 
______________________ 
This dissertation follows the style of Environment International. 
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(Fig. 1-1).  Complex chemical mixtures are generated by many sources, including 
natural events such as forest fires and volcanic eruptions, hundreds of industrial 
operations, mining activities, and combustion of fuels such as petroleum products, 
wood, and coal.  These mixtures can then be released to the environment as air 
emissions, industrial effluents, or leaks and spills from improper storage and handling. 
 
 
SOURCE
Natural processes
Industrial operations
Combustion
RELEASE
Spills, runoff, leaching
Industrial effluents
Air emissions
TRANSPORT
Media partitioning
Atmospheric transport
Groundwater flow
TRANSFORMATION
UV degradation
Chemical reactions
Biodegradation
RECEPTOR
Adults
Children
Ecological
 
 
Fig. 1-1. Environmental exposure model. 
 
 
Once a mixture is released into the environment, it is acted upon by 
transformation and transport processes that can change the composition of the mixture 
and move it far away from the point of release.  Compounds may partition into other 
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environmental media; this partitioning will often change the mixture composition 
because different physicochemical properties of mixture components will cause them to 
partition differently.  For example, components of crude petroleum have a wide range of 
volatility and aqueous solubility.  When crude oil is spilled in a marine environment, 
some compounds will readily evaporate into the air, others will easily dissolve in water, 
and the remainder will mainly adsorb to solid particles in the water and eventually settle 
to the bottom sediments or be taken up by marine organisms.  Mixture components may 
also undergo chemical reactions with other compounds and may be degraded by UV 
light exposure or by biological organisms.  Transport processes can be as simple as 
movement downstream of an industrial effluent released into a river, or complex, 
involving multiple environmental media.  Long-range atmospheric transport processes 
are responsible for deposition of some mixtures thousands of miles from where they 
were released.  Examples of long-range atmospheric transport include the 
contamination of arctic snows with polychlorinated biphenyls (PCBs), and dust carried 
to the U.S. across the Atlantic Ocean from Africa and across the Pacific Ocean from 
Asia.  
Receptors are exposed to environmental mixtures when they come into contact 
with contaminated environmental media.  Common media of exposure for humans are 
indoor air, outdoor air, drinking water, house dust, and foods.  Humans may be exposed 
at work and at home.  Occupational exposures to mixtures may be significant.  For 
example, an occupational study of soil remediation workers in a former creosote wood 
impregnation site demonstrated significant work-related exposure to mixtures of PAHs 
(Elovaara et al., 2006). 
Exposures at home include mixtures generated by building materials, 
furnishings, clothing, cooking, combustion of fuels, tobacco and candles, and by use of 
personal care products, cleaning products, home maintenance products, and lawn and 
gardening equipment.  Use of tap water for bathing, cooking, washing, and sanitation 
can release volatile contaminants into indoor air.  Environmental tobacco smoke (ETS), 
the combustion product mixture that enters the surrounding air when tobacco is 
smoked, is a widespread contaminant of indoor air.  Serum cotinine, a biomarker of 
ETS exposure, was detectable in 84% of a sample of approximately 4400 U.S. children 
aged 6 to 16 (Yolton et al., 2005). 
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Foods can be a major source of human exposure to environmental mixtures.  
Plants, livestock and wildlife which have been exposed to chemical mixtures in the 
environment can absorb and accumulate contaminants.  Contaminated plants and 
animals that are used as food become a source of exposure for humans.  For example, 
many large lakes are contaminated by pollutants such as PCBs that tend to accumulate 
in the fatty tissue of aquatic organisms.  Fish caught from these lakes can be a 
significant source of food and exposure for people living near the lake. 
Exposure occurs when an individual comes into superficial contact with an 
environmental mixture.  Exposure may take place by any of three routes: inhalation, 
ingestion, and dermal contact.  Before the mixture can cause a health effect, the 
mixture must be absorbed; i.e., it must cross a cell membrane and enter the body.  
Absorption from dermal contact can occur anywhere on the surface of the body.  
Absorption by inhalation can take place anywhere in the respiratory tract, from the nasal 
passages to the alveoli in the lungs.  Likewise, by the ingestion route, absorption can 
occur throughout the digestive tract, from the mouth to the colon. 
Absorption is a toxicokinetic process.  Toxicokinetic processes determine the 
fate of a chemical once it comes into contact with an organism (Table 1-1).  Distribution 
is the transport of a chemical through the body, usually by a circulatory system (blood or 
lymph), to tissues distant from the site of absorption.  This can be an important factor in 
toxicity because the susceptible tissue may be different from the absorption tissue.  
Elimination is the process by which a contaminant leaves an organism by again 
crossing a cell membrane.  Elimination can take place through the skin and exterior 
surfaces, the lungs, the kidneys, and the digestive tract. 
 
Table 1-1 
Toxicokinetic processes  
Process Description 
Absorption Entry into body by crossing a cell membrane 
Distribution Transport through body 
Metabolism Chemical modification by cellular enzymes 
Elimination Exit from body by crossing a cell membrane 
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Metabolism, also called biotransformation, is the chemical modification of a 
compound by cellular enzymes.  Metabolism may take place in the absorption tissue or 
after distribution to other tissues.  Most body tissues have some metabolic capability.  
Major sites of xenobiotic metabolism include the liver and the small intestine.  
Generally, metabolism makes xenobiotics more water soluble by the addition of 
functional groups.  This increases excretion of the xenobiotic from the cell, thus 
detoxifying the xenobiotic.  However, some xenobiotics are also transformed by cellular 
metabolism into more toxic forms (‘bioactivation’).  The rate and extent of metabolism 
are often dependent on the similarity of the compound to an endogenous substrate; 
however, many common xenobiotic-metabolizing enzymes have broad substrate 
specificity. 
1.2.2 Health Effects of Environmental Mixtures 
Linking environmental exposures to observed health effects is often challenging.  
The chronic, low-level doses typical of environmental exposures in the general 
population may cause health effects that, although significant and clinically relevant in 
the long-term, are subtle and difficult to measure.  When health effects are detectable, 
establishing the level of exposure and isolating the effects of the mixture from those of 
concurrent exposures are additional challenges.  Another level of complexity in the 
analysis of mixture toxicity is added because health effects may vary with exposure 
route. 
Because of these challenges, toxicity assessment of mixtures may require a 
weight-of-evidence approach, in which accumulated evidence from a variety of studies 
is evaluated.  These may include: 1) occupational epidemiological studies showing 
associations between worker exposure levels and disease incidence, 2) human 
biomarker studies linking environmental exposure and sub-clinical effects, 3) health 
effects in lab animals from direct administration of the mixture, and 4) in vitro studies 
demonstrating mechanisms of toxicity.  While none of these studies alone may be 
sufficient to establish the toxicity of a mixture, when evaluated together, the combined 
evidence may be strong enough for conclusions to be made by regulatory agencies. 
1.2.2.1 Effects of Selected Common Environmental Mixtures 
The health effects of several environmental mixtures are summarized below.  
These mixtures are significant to human health because they are common 
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environmental contaminants and many people are chronically exposed to them.  
Toxicological Profiles of three of the mixtures have been published by the Agency for 
Toxic Substances and Disease Registry (ATSDR).  ATSDR Toxicological Profiles are 
reviews of the key literature that describes a hazardous substance’s toxicological 
properties and adverse health effects.  Much of the evidence of human health effects 
associated with the selected environmental mixtures comes from studies of 
occupational or accidental exposures to relatively large amounts of the mixtures.  Lab 
animal and in vitro studies provide additional evidence of toxicity. 
Automotive Gasoline.  Automotive gasoline is a complex mixture of refined 
petroleum hydrocarbons with small amounts of additives and blending agents.  The 
composition varies seasonally and with the crude oil source and manufacturing 
processes.  Humans are frequently exposed to gasoline by breathing gasoline vapors 
while filling vehicle fuel tanks.  Exposure may also occur during filling and operation of 
gasoline-powered equipment such as lawn mowers.  Significant occupational exposure 
may occur among workers in service stations, petroleum refineries, bulk loading 
terminals, marine loading docks, and among drivers of gasoline tank trucks (ATSDR, 
1995a).  Acute exposures to large amounts of gasoline by inhalation or ingestion have 
caused death in humans.  Gasoline is a skin, respiratory, and gastrointestinal irritant.  
Neurological effects of acute exposures to gasoline vapors increase in severity with 
increasing duration and dose, and range from dizziness, headaches and euphoria to 
numbness, anesthesia and coma.  Many effects of chronic exposure to gasoline have 
also been associated with exposure to gasoline components lead and benzene.  Long-
term inhalation of gasoline caused liver and kidney tumors in lab animals.  In human 
occupational studies, there is some evidence of increased cancer risk and mortality, but 
it is compromised by lack of accurate exposure data for gasoline and concurrent 
exposures to other carcinogens, and lack of adjustment for confounding factors such as 
smoking (ATSDR, 1995a). 
Polychlorinated Dibenzo-p-dioxins (PCDDs).  PCDDs, also called ‘dioxins’, are a 
family of environmental contaminants that occur in mixtures.  PCDDs are byproducts of 
production of some pesticides, chlorine bleaching processes used at pulp and paper 
mills, and incomplete combustion of organic matter.  PCDDs occur nearly everywhere in 
the environment and most humans have frequent, low-level exposure to environmental 
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PCDD mixtures.  PCDDs accumulate in living tissues and therefore in the food chain.  
More than 90% of PCDD exposure in the general population is through food, mainly 
from meat, fish, and dairy products (ATSDR, 1998).  Occupational exposure to PCDDs 
may occur in people who work in pulp and paper mills, at hazardous waste sites, 
municipal and hazardous waste incinerators, and those involved in production, use, and 
disposal of chlorinated pesticides and herbicides.  The most toxic of the PCDDs, 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), is the reference compound for PCDD toxic 
equivalency factors which are used in risk assessment (Safe, 1990).  Most evidence of 
PCDD toxicity in humans has come from studies of occupational exposures, exposures 
due to accidental spills of mixtures containing PCDDs, and exposures due to large-
scale aerial spraying of PCDD-contaminated herbicides by the United States in 
Vietnam.  In these studies, exposure levels and specific routes of exposure are difficult 
to determine, and confounding effects of concurrent exposure to other toxic mixtures 
are present.  PCDDs have clearly been shown to cause chloracne, a severe skin 
disease characterized by acne-like lesions which usually occur on the face and upper 
body (ATSDR, 1998).  The International Agency for Research on Cancer (IARC), the 
U.S. Environmental Protection Agency (USEPA), and the U.S. Department of Health 
and Human Services recognize the likelihood that TCDD may cause cancer in humans 
(ATSDR, 1998).  There is a large body of evidence of PCDD toxicity in laboratory 
animals, but toxicity varies significantly between species, and intraspecies differences in 
sensitivity may be related to sex, age, and strain (ATSDR, 1998; Safe, 1990).  Health 
effects observed in lab animals exposed to high doses of PCDDs include chloracne, 
weight loss, mortality, reproductive toxicity, developmental toxicity, cancers of liver and 
thyroid, hepatotoxicity, immunotoxicity and endocrine effects (ATSDR, 1998). 
Polychlorinated Biphenyls (PCBs).  PCBs were manufactured, prior to being 
banned in the U.S. in 1977, for use in electrical transformers, capacitors, heat transfer 
fluids, lubricants, and many consumer products.  PCB mixtures consist of molecules 
with varying degrees of chlorination.  The same characteristics that made PCB mixtures 
desirable for use (chemical and thermal stability, low aqueous solubility) have made 
them extremely resistant to breakdown in the environment.  Occupational exposures to 
PCBs, which may be released during repair, maintenance or disposal of items 
containing PCBs, usually occur by inhalation or dermal contact.  Like PCDDs, PCBs are 
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present at low levels almost everywhere in the environment and accumulate in the food 
chain, contributing to the exposure of the general population (ATSDR, 2000).  Studies 
of workers exposed to PCBs have reported irritation of the nose and lungs, depression, 
fatigue, and gastrointestinal discomfort.  Occupational studies have also associated 
PCB exposure with cancers of the skin, liver and biliary tract.  Chronic oral exposure of 
rats to PCBs induced liver tumors.  USEPA and IARC classify PCBs as probable human 
carcinogens.  Developmental and immune system effects have been documented in 
children whose mothers were exposed to PCBs.  Maternal exposure in lab animals was 
associated with harmful behavioral effects, prenatal death, and changes in the immune 
system, thyroid and reproductive system of offspring (ATSDR, 2000). 
Environmental Tobacco Smoke.  The health effects of active smoking have long 
been known, and there is also a significant body of evidence linking ETS exposure to 
adverse health effects in humans.  ETS is a complex mixture of organic compounds and 
metals that results from the combination of exhaled mainstream smoke and the 
sidestream smoke from the burning tip of a cigarette.  ETS exposure is generally an 
indoor exposure, occurring in workplaces and residences in which people are actively 
smoking.  Infants whose mothers were exposed to ETS have increased risk of preterm 
birth and reduced birth weight (Wigle et al., 2007).  Childhood ETS exposure can 
increase incidence and severity of asthma, recurrence of middle ear infections, and 
prevalence and severity of respiratory infections (Ciencewicki and Jaspers, 2007; Wigle 
et al., 2007).  Fetal or childhood ETS exposures have been associated with adverse 
effects on behavior and cognitive functioning (Reardon, 2007).  Evidence links ETS 
exposure to increased risk of chronic obstructive pulmonary disease and stroke, and 
workplace ETS exposure has been causally related to lung cancer risk (Jaakkola and 
Jaakkola, 2006).  Significant reductions in worker ETS exposure due to smoke-free 
workplace legislation have been accompanied by increases in lung function levels and 
reductions in respiratory symptoms and acute myocardial infarctions (Jaakkola and 
Jaakkola, 2006). 
1.2.2.2 Toxicity Mechanisms 
Two predominant molecular mechanisms for xenobiotic toxicity are oxidative 
stress and covalent binding to cellular macromolecules (Nebert, 1999).  Xenobiotics 
cause oxidative stress by undergoing redox cycling and generating damaging free 
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radicals.  When a xenobiotic covalently binds to proteins or nucleic acids, it can disrupt 
the critical function of these macromolecules (Gregus and Klaassen, 2001).  Oxidative 
stress and covalent binding can cause cell-level effects such as apoptosis, perturbation 
of differentiation, and alteration of metabolism, cell growth, homeostasis, and 
neuroendocrine signals (Nebert, 2000).  When these cell-level effects continue and 
occur in many cells, they eventually lead to tissue-level and organ-level effects and 
diseases such as those discussed in the previous section. 
 
 
TOXICITY
Oxidative stress,
Covalent binding
Phase I
XMEs
X
X
T
X O
X O Conj
Phase II
XMEs
T X O Conj
Cell membrane
(Step 1)
(Step 2)
(Step 5)
(Step 4)
(Step 3)
 
 
Fig. 1-2. Cellular model of xenobiotic fate and toxicity.  X = xenobiotic, X-O = phase I 
metabolite, X-O-Conj = phase II metabolite, XMEs = xenobiotic-metabolizing enzymes,  
T = membrane-bound transporter. 
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A general model of the cellular fate and toxicity of xenobiotics includes five steps 
(Fig. 1-2).  In Step 1, the xenobiotic (X) is taken up by the cell.  It crosses the cell 
membrane by diffusion or is assisted by a membrane-bound transport protein (T).  Once 
inside the cell, the xenobiotic encounters phase I xenobiotic-metabolizing enzymes 
(XMEs) in either the cytoplasm or the endoplasmic reticulum.  Step 2 is transformation 
by these enzymes to a phase I metabolite, which is often an oxidized form (X-O).  Some 
xenobiotics are toxic in their unmodified (parent) form; for these compounds, phase I 
metabolism is a detoxification step.  Other xenobiotics are activated by phase I 
metabolism and the phase I metabolite causes the toxic effects.  Step 3 is the 
generation of toxic effects by the active form.  Step 4 is the addition of a conjugate such 
as glutathione by phase II XMEs; this forms a phase II metabolite (X-O-Conj).  Phase II 
metabolism detoxifies active phase I metabolites and prepares the compound for 
excretion.  In Step 5 the phase II metabolite is readily excreted by a membrane-bound 
transporter. 
1.2.2.3 Mixture Interactions 
Most available toxicity data is for individual compounds.  The toxicity of 
environmental mixtures is often assessed by determining the chemical composition of 
the mixture and assuming that the toxicity of individual components is additive.  This 
approach is useful in the absence of information on whole mixture toxicity, but assumes 
that the full chemical composition of the mixture is known and that toxicity data is 
available for all the components.  These criteria are difficult to meet for complex 
mixtures.  Even if the mixture composition and component toxicities are fully 
characterized, interactions among the mixture components may make the overall 
mixture toxicity less than or more than additive. 
In some cases, direct chemical interaction occurs among mixture components.  
For example, the genotoxicity of both 2,4,6-trinitrotoluene and benzo[a]pyrene (BaP) 
was suppressed when they were co-administered in a microbial bioassay (Washburn et 
al., 2001).  Chemical analysis revealed that the compounds had formed reaction 
products which presumably decreased their bioavailability. 
Mixture components may interact through toxicokinetics.  Effects on metabolism 
are of particular interest because of the important role metabolism plays in both 
elimination and toxicity.  Mixture components may increase metabolism by inducing 
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XMEs or decrease metabolism by inhibiting or saturating XMEs.  An example is the 
synergistic hepatotoxicity of acetaminophen or carbon tetrachloride when combined 
with ethanol.  The ethanol increases toxicity of acetaminophen and carbon tetrachloride 
by upregulating CYP2E1 and depleting glutathione (Treinen-Moslen, 2001). 
Interactions of PAHs in mixtures have been evaluated both in vivo and in vitro.  
Most of these mixture studies involve simple mixtures of two or three compounds.  
Though the interactions in complex mixtures may be more complicated, these studies 
are a valuable starting point and, in some cases, provide information on mechanisms of 
interaction. 
Cherng et al. (2006) found that the genotoxicity of the PAH benzo[a]pyrene 
(BaP) in HepG2 cells decreased with co-treatment with 1-nitropyrene (1-NP) in a dose-
dependent manner.  Further study revealed that co-treatment with 1-NP decreased 
CYP1A1 mRNA levels and increased degradation of CYP1A1 protein, an important 
enzyme in the bioactivation of BaP. 
Genotoxicity of BaP and another genotoxic PAH, dibenzo[a,l]pyrene (DBP), 
alone and in mixtures was studied in human diploid lung fibroblasts (Binkova and Sram, 
2004).  Binary mixtures of BaP or DBP with other PAHs were less genotoxic (lower 
DNA binding) than BaP or DBP alone.  Also, BaP administered as part of a complex 
mixture, extractable organic matter from respirable air particles, was significantly less 
genotoxic than the same dose of BaP alone.  The authors suggest that the attenuation 
of BaP genotoxicity may result from competitive inhibition of bioactivating XMEs 
because the metabolic capacity of the cell system utilized is relatively low. 
In an in vivo toxicity study, BaP and 3’-methoxy-4’-nitroflavone (MNF) were 
administered to C57B1/6J mice and AhR-null mice by intraperitoneal injection 
(Dertinger et al., 2000).  Bone marrow toxicity was measured by frequency of peripheral 
blood reticulocytes and genotoxicity was measured by frequency of micronuclei in 
reticulocytes.  BaP genotoxicity and bone marrow toxicity were significantly decreased 
by co-administration of MNF in both mouse strains.  However, lethality and abnormal 
histology of spleen and intestine were enhanced by co-administration of MNF in both 
mouse strains.  Further investigation of MNF in vitro (Hepa1c1c7 cells) demonstrated 
that MNF inhibited both CYP1A1/2 enzyme activity and AhR-dependent transcription of 
a reporter gene with a dioxin responsive element.  The authors suggest that the 
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interactions between BaP and MNF occur through both AhR- dependent and AhR-
independent mechanisms (Dertinger et al., 2000). 
In an in vivo tumor-initiation assay, BaP and various coal-derived complex 
mixtures were applied to the skin of female CD-1 mice.  Co-administration of BaP with 
each of four complex mixtures resulted in fewer skin tumors and reduced DNA binding 
of BaP by 50-85% (Springer et al., 1989).  Hughes and Phillips (1990) reported that 
various binary mixtures of PAHs exhibited additive, synergistic or antagonistic effects on 
DNA adduct levels when applied to mouse skin. 
1.2.3 Genetic Susceptibility 
The risk of health effects from exposure to an environmental mixture depends 
not only on exposure levels and route, but also on individual factors such as age, sex, 
developmental status, general health, nutrition, concurrent exposures, and genetics.  
The study of genetic susceptibility (inherited variation in response) to exposure to 
environmental agents is part of the field of ecogenetics (Faustman and Omenn, 2001).  
The goal of ecogenetic studies is to establish a correlation between a quantifiable 
variation in response to exposure (phenotype) and genetic polymorphisms (genotype). 
One of the fundamental concepts in toxicology is that of the dose-response 
relationship, also called the exposure-effect relationship.  For most environmental 
toxicants, there is a gradual increase in the level of toxic effects as the environmental 
exposure increases.  If enough data is available, a quantitative relationship between 
exposure and toxic effects can be developed.  Fig. 1-3, adapted from Nebert (1999), is 
a generalized representation of a simple linear exposure-effect relationship.  Data 
points which are statistical outliers represent separate phenotypes from the general 
population.  Those for which a relatively large exposure results in little or no toxicity are 
considered to be “resistant” phenotypes, and those for which there is an exaggerated 
response to a relatively low exposure are considered to be “sensitive” phenotypes 
(Nebert, 1999).  Ecogenetic studies seek to identify genetic polymorphisms that are 
associated with these phenotypes and to determine the underlying mechanism for the 
genotype/phenotype relationship. 
Differences in the regulation, expression, and activity of XMEs can change 
tissue concentrations, bioactivation/detoxification, excretion, and, ultimately, toxic 
effects of a xenobiotic.  Genetic polymorphisms of many XMEs have been identified and 
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large interindividual variation in activity of some XMEs has been reported (Autrup, 
2000).  Some of these changes in XME metabolic capability are significant enough to 
lead to measurable differences in susceptibility to environmental agents.  Many 
ecogenetic studies have focused on polymorphisms in XME genes. 
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Fig. 1-3. Exposure-effect relationship.  Adapted from Nebert (1999). 
 
 
The cytochrome P450 (CYP) enzymes are a superfamily of heme-thiolate mono-
oxygenases which are important in many cellular functions, including synthesis of 
steroids, cholesterol, and bile acids (Nebert and Dalton, 2006).  Because of their broad 
substrate specificity, the CYP enzymes are also important phase I XMEs for many 
xenobiotics.  An estimated 70-80% of phase I XMEs belong to the CYP family (Evans 
and Relling, 1999).  Although phase I metabolism is an important step in the 
detoxification and excretion of xenobiotics, CYP-mediated phase I metabolism may also 
activate xenobiotics by transforming them into toxic reactive oxygenated intermediates 
(X-O in Fig. 1-2).  In an extensive review of studies evaluating potential links between 
CYP gene polymorphisms and cancer risk, Agundez (2004) found consistent evidence 
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for associations between CYP polymorphisms and risk of lung, liver, and head/neck 
cancers.  Specifically, CYP1A1 polymorphisms were associated with lung cancer risk, 
and CYP2D6 polymorphisms were associated with lung and liver cancer risk.  Weak 
associations have been identified of CYP1A1 (Murata et al., 2001) and CYP1B1 
(Tanaka et al., 2002) with prostate cancer risk, and CYP2A6 and CYP2C19 with 
colorectal cancer risk (Sachse et al., 2002). 
The glutathione S-transferase (GST) family of enzymes is a group of phase II 
XMEs.  GSTs detoxify and enhance excretion of xenobiotics by catalyzing the 
conjugation of glutathione with electrophilic phase I xenobiotic metabolites (Step 3 in 
Fig. 1-2).  Null genotypes (gene deletion) of enzymes GSTM1 and GSTT1, which result 
in no enzymatic activity, have been identified in humans.  In a study of Czech 
newborns, the GSTM1 and GSTT1 null genotypes were significantly associated with 
decreased birth weight among newborns whose mothers smoked (Sram et al., 2006).  
Each null genotype was associated with a significantly increased risk of acute 
lymphoblastic leukemia in a meta-analysis of 30 published case-control studies (Ye and 
Song, 2005).  In another meta-analysis of epidemiological studies, the GSTT1 null 
genotype was significantly associated with risk of adult meningioma (Lai et al., 2005). 
The UDP-glucuronosyl transferases (UGTs) are another family of conjugating 
enzymes involved in the phase II metabolism of xenobiotics.  UGTs catalyze 
glucuronidation of phase I xenobiotic metabolites, which enhances xenobiotic 
detoxification and excretion.  Alleles of UGT1A7 have been identified which are 
associated with lower glucuronidation activity than the wild-type allele.  Individuals 
carrying any of the reduced-activity alleles were found to have a higher risk of 
orolaryngeal cancer than individuals with the wild-type genotype (Zheng et al., 2001).  
The low-activity allele UGT1A7*3 has been significantly associated with hepatocellular 
carcinoma (Vogel et al., 2001) and colorectal cancer (Strassburg et al., 2002). 
Polymorphisms in XME genes are not the only source of genetic variation in 
xenobiotic-metabolizing capability.  In the last two decades, as knowledge of cell 
signaling pathways has expanded, the importance of intracellular receptors in the 
regulation of XME expression and activity has been increasingly recognized.  Nuclear 
receptors such as aryl hydrocarbon receptor (AhR) and pregnane X receptor (PXR) 
form ligand-activated transcription factor complexes which can interact with the 
 15 
regulatory regions of XME genes and either induce or inhibit transcription, leading to a 
change in XME gene expression and cellular enzyme levels and activity.  Some nuclear 
receptors, such as PXR and constitutive androstane receptor (CAR) also regulate 
expression of membrane-bound transport proteins, which can increase or decrease 
cellular excretion of xenobiotic metabolites.  In these ways, genetic polymorphisms 
which affect the functioning of receptors can cause variation in susceptibility to 
xenobiotics.  AhR regulates many XMEs, including CYP1A1, CYP1A2, CYP1B1, 
GSTA1, and UGT1A6/7 (Nebert and Dalton, 2006).  Although evidence of the effect of 
AhR polymorphisms in humans is not plentiful, a few recent epidemiological studies 
suggest an association of various AhR polymorphisms with lung cancer risk, breast 
cancer risk, and survival of soft tissue sarcoma (Berwick et al., 2004; Kim et al., 2007; 
Long et al., 2006). 
 
1.3 Polycyclic Aromatic Hydrocarbons 
1.3.1 Chemical Structure and Properties 
Polycyclic aromatic hydrocarbons (PAHs) are a class of organic compounds 
consisting of two or more fused aromatic rings (Fig. 1-4).  PAHs that consist exclusively 
of six-membered (benzenoid) aromatic rings are classified as alternant (Dabestani and 
Ivanov, 1999).  Examples of alternant PAHs include phenanthrene, chrysene, 
benz[a]anthracene and benzo[a]pyrene (Fig. 1-4).  PAHs such as fluoranthene and 
benzo[b]fluoranthene contain 5-membered aromatic rings and are classified as non-
alternant PAHs.  Another method of PAH structural classification is based on the shape 
formed by lines that are drawn between the centers of the rings.  In peri-condensed 
PAHs, the connecting lines form cycle patterns (Ramesh et al., 2004).  Examples of 
peri-condensed PAHs are fluoranthene, benz[a]anthracene, benzo[a]pyrene, and 
benzo[b]fluoranthene (Fig. 1-4).  In cata-condensed PAHs such as phenanthrene and 
chrysene, the connecting lines form linear or angular patterns, not cycles.  Because of 
the shape of five-membered rings, non-alternant PAHs are always peri-condensed 
(Ramesh et al., 2004).  
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Naphthalene
Benz[a]anthracene
2-Methylnaphthalene
Fluoranthene
Benzo[a]pyrene
ChrysenePhenanthrene
Benzo[b]fluoranthene
 
Fig. 1-4. Chemical structures of representative PAHs. 
 
 
Unsubstituted (parent) PAHs, consisting of only fused aromatic rings, are the 
basic PAH structure.  Substituted PAHs have one or more chemical groups substituted 
for hydrogen atoms on exterior carbon atoms.  An example of a parent PAH and one of 
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its substituted PAH derivatives are naphthalene and 2-methylnaphthalene, respectively 
(Fig. 1-4).  The substituted groups may be alkyl chains or may contain heteroatoms 
such as nitrogen, sulfur, or oxygen.  Substituted PAHs which contain only alkyl groups, 
without heteroatoms, will be referred to here as ‘alkyl-substituted’ or ‘alkylated’ PAHs.  
PAHs can be grouped together in “families” which consist of the parent PAH and a 
series of alkyl-substituted derivatives of the parent (Boehm, 2006). Common analytical 
techniques such as gas chromatography/mass spectrometry detect alkylated PAHs as 
peaks with varying numbers of alkyl carbons.  For example, C2-naphthalenes include 
both ethyl-substituted and dimethyl-substituted naphthalenes.  The naphthalene family 
includes the parent naphthalene, C1-naphthalenes, C2-naphthalenes, C3-naphthalenes, 
and C4-naphthalenes. 
PAHs are chemically stable at atmospheric conditions mainly because of their 
aromaticity.  Aromatic bonds are very stable because the orbitals have hybridized and 
the valence electrons are shared among the carbon atoms.  At atmospheric 
temperature and pressure, often a concentrated energy source (e.g., UV light) or a 
catalytic process (e.g., biological enzymes) is required to break aromatic bonds.  The 
aromatic structure is generally planar.  Alkylation can distort the planar structure of the 
rings and may result in higher reactivity (Dabestani and Ivanov, 1999). 
In such a large chemical class, there is a wide range of physical properties.  
PAHs can be roughly divided into two molecular weight groups by the number of 
aromatic rings: PAHs with 2 or 3 rings are low molecular weight (LMW); PAHs with four 
or more rings are high molecular weight (HMW).  In Fig. 1-4, naphthalene, 2-
methylnaphthalene and phenanthrene are LMW PAHs; the rest of the PAHs in the 
figure are classified as HMW.  Both aqueous solubility and vapor pressure tend to 
decrease with increasing molecular size.  LMW PAHs are sparingly soluble in water and 
tend to exist in the vapor phase.  In general, HMW PAHs have low aqueous solubility, 
low vapor pressure, and high melting and boiling points (Albers, 2003). 
HMW PAHs are persistent in the environment because of their physical 
properties as well as the chemical stability of their bonds.  For example, benzene is an 
aromatic ring but is much more easily degraded than most PAHs because of the 
difference in physical properties.  The low aqueous solubility of PAHs limits their 
bioavailability to microorganisms in the environment which could enzymatically degrade 
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them.  It also causes them to partition out of aqueous phases to solid phases such as 
soils and sediments, which can limit their exposure to UV light.  Uptake of PAHs by 
microorganisms can be limited by the size of the molecule. 
1.3.2 Sources 
PAHs are formed by three main processes: diagenesis, petrogenesis, and 
pyrolysis.  Diagenesis and petrogenesis are typically naturally-occurring, whereas 
pyrolysis can be the result of natural or anthropogenic events.  Diagenesis occurs in 
organic matter that has been deposited in soils or sediments.  In these oxygen-depleted 
environments, aromatization reactions occur which convert organic molecules into 
PAHs.  These formation pathways may involve both microorganisms and non-biological 
chemical processes (Boehm, 2006).  Diagenesis occurs at low temperature, over a 
span of days to years, and produces a relatively simple mixture of PAHs compared to 
other PAH-formation processes.  PAHs formed by diagenesis may migrate from their 
point of origin into ground or surface water.  In addition, diagenic PAHs may be 
distributed when soils and sediments are disturbed by excavation and dredging. 
Petrogenesis is further diagenesis of organic matter in deeply buried layers of 
sediments at higher temperatures and pressures over the course of millions of years 
(Boehm, 2006).  Fossil fuels petroleum and coal are formed by petrogenesis and may 
contain hundreds to thousands of PAH compounds of varying chemical structures.  
Petrogenic PAH mixtures typically contain mainly 2-ring to 6-ring PAHs.  In these 
mixtures, alkylated PAHs are more abundant than unsubstituted PAHs (Boehm, 2006).  
Release of petrogenic PAHs from fossil fuels into the environment may occur naturally 
(e.g. petroleum seeps), or from human extraction activities such as mining and drilling.  
Crude oil spills in water and on land are a source of environmental PAH contamination.  
Petroleum refining generates products in which PAHs may be concentrated, such as 
diesel fuel, solvents, and lubricating oils.  Use and spills of these products also release 
PAHs into the environment.  
Complex mixtures of pyrogenic PAHs are formed by pyrolysis, a rapid process 
which occurs at high temperatures in oxygen-depleted environments.  Pyrogenic PAH 
mixtures generally contain a higher ratio of unsubstituted PAHs to alkylated PAHs than 
do petrogenic PAH mixtures.  Higher pyrolysis temperatures tend to create PAHs with 
more aromatic rings than do lower temperatures (Boehm, 2006).  Coke production and 
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coal gasification are high-temperature anoxic processes that produce pyrogenic PAH 
mixtures.  Coal tar, a by-product of these processes, is rich in PAHs.  Many production 
sites are contaminated by coal tar that has been spilled onto soil and/or leached into 
groundwater.  Coal tar is used for wood preservation; releases of coal tar PAHs can 
occur from the wood preservation process itself and when the coal tar leaches from 
preserved wood.  Pyrogenic PAHs are also formed during high-temperature cooking of 
meats and oils.  These PAHs enter the air as part of cooking fumes and also remain on 
the food. 
The most common pyrolysis process is the incomplete combustion of organic 
matter, including fossil fuels and refined products from fossil fuels.  Combustion of 
wood, tobacco products, and other biomass also produces PAHs.  Important sources of 
pyrogenic PAHs released to the atmosphere include forest and prairie fires, agricultural 
and refuse burning, heating and power generation, industrial processes, and mobile 
sources (Latimer and Zheng, 2003).  Motor vehicles, residential boilers, waste 
incinerators and industrial operations can be important sources of pyrogenic PAHs in 
urban environments (ATSDR, 1995b).  In a study of the impact of motor vehicle traffic 
on residential indoor air PAH concentrations, outdoor PAH contributions were highest at 
the high traffic location; peaks in indoor PAH concentrations occurred on weekdays 
during rush-hour traffic periods (Dubowsky et al., 1999).  A study of residences near an 
industrial source found a correlation between indoor and outdoor concentrations of 4-6 
ring PAHs (Sanderson and Farant, 2004). 
Pyrogenic PAHs may also be generated by indoor sources.  Typical indoor 
sources include combustion of fossil fuels and biomass for heating and cooking; burning 
of tobacco products, candles and incense; and cooking fumes.  Many residences rely 
on combustion of fuel for heating and cooking.  Combustion sources include central 
furnaces, stoves, portable space heaters, and fireplaces for heating, as well as ovens 
and stovetops for cooking.  Fuels used are natural gas, liquefied propane and butane, 
kerosene, heating oil, coal, wood, and other biomass (e.g., agricultural waste). 
Indoor activities may also contribute to outdoor PAH contamination.  A variety of 
studies in Scandinavia, Canada, the United Kingdom, and the United States highlight 
the role of indoor wood combustion in determining ambient particulate matter and PAH 
contamination levels, including evidence that residential wood combustion contributes 
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up to 90% of wintertime ambient PM2.5 in Seattle, Washington, USA (Boman et al., 
2003; Prevedouros et al., 2004).  Although properly maintained and functioning wood 
burning stoves directly contribute little to the indoor air PAH concentration of the 
residence in which they are used, they emit PAHs into the ambient air and thus 
indirectly affect the indoor air quality of homes in the surrounding area (Lewtas et al., 
1992). 
1.3.3 Environmental Distribution 
PAHs are distributed widely in the environment and occur as complex chemical 
mixtures.  PAHs have been detected in ambient air (urban, suburban and rural), indoor 
air, groundwater, drinking water, surface water, atmospheric precipitation (rain, snow 
and fog), soil, sediments (marine and freshwater), and biota (terrestrial and aquatic 
plants and animals) (Menzie et al., 1992; National Library of Medicine, 2004).  PAHs 
have been detected in at least 600 National Priorities List hazardous waste sites 
identified by USEPA, and fifty-four PAHs have been identified at one or more of these 
sites (ATSDR, 1995b).  Sixteen PAHs are included in USEPA’s priority pollutant list, a 
list mandated by provisions of the Clean Water Act of chemicals which must be 
monitored in wastewater. 
PAHs are emitted from sources directly into various environmental media, such 
as combustion emissions into the ambient air, and petroleum spills into water or soil.  
Once the emission has occurred, environmental transport processes can distribute the 
PAHs far away from the source.  Wind currents can carry combustion emissions many 
miles.  A petroleum spill on land can run off into surface waters that eventually run to 
the ocean, or seep through the soil into flowing underground aquifers. 
PAHs are also distributed by partitioning between environmental media.  LMW 
PAHs released to the air will generally exist in the vapor phase and may be degraded 
by reaction with photochemically-produced radicals in a relatively short time (ATSDR, 
1995b).  HMW PAHs will partition almost completely into the particulate phase, 
adsorbed to fine particles which are suspended in the air.  These particle-bound PAHs 
may be transferred to soil or surface waters dry or wet deposition.  Long-range transport 
of airborne particle-bound PAHs from Great Britain to Norway and Sweden has been 
documented (ATSDR, 1995b). 
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Volatilization may be an important partitioning process for LMW PAHs released 
into water, but HMW PAHs do not volatilize appreciably (Dabestani and Ivanov, 1999).  
Due to their poor aqueous solubility, HMW PAHs in water are more likely to be 
adsorbed to suspended particles in the water column than to be dissolved (Latimer and 
Zheng, 2003).  These suspended particles eventually settle to the bottom sediment, 
carrying the PAHs with them.  In the marine environment, sediments are the primary 
repository of PAHs and the PAH distribution of sediment samples is dominated by 4- to 
6-ring PAHs (Latimer and Zheng, 2003).  PAHs in water and sediments can be sorbed 
to or accumulated by aquatic organisms (ATSDR, 1995b). 
LMW PAHs released to or deposited on soil may volatilize appreciably or be 
broken down by soil microorganisms.  HMW PAHs will tend to adsorb to soil particles.  
The physical properties of HMW PAHs limit their bioavailability and make them resistant 
to biodegradation (Dabestani and Ivanov, 1999).  PAHs may migrate through soil into 
groundwater (ATSDR, 1995b). 
In addition to occurring in environmental media, PAHs have also been detected 
in many living organisms, both plants and animals.  Because of their stability and low 
aqueous solubility, HWM PAHs tend to accumulate in some biota.  Bioconcentration 
depends on the metabolic capabilities of the organism (ATSDR, 1995b).  Terrestrial 
plants take up PAHs from soil through the roots or via atmospheric deposition on the 
foliage.  Likewise, aquatic plants may absorb PAHs from the water column or from the 
sediments in which they grow.  Aquatic animals may take in PAHs from contact with 
sediments or suspended particles in the water.  PAHs are also part of the food chain; 
however, biomagnification of PAH concentrations through the food chain appears to be 
limited (ATSDR, 1995b).  Terrestrial animals may be exposed to PAHs by ingestion of 
contaminated soil or through the food chain (ATSDR, 1995b). 
1.3.4 Health Effects 
1.3.4.1 Genotoxicity 
Genotoxic chemicals affect the genetic material and/or genetic processes of 
cells, acting by directly damaging DNA or by altering cellular functions such as DNA 
repair, mitosis, and control of cell proliferation.  Genotoxic endpoints such as mutations 
and DNA strand breaks can lead to adverse health effects, including cancer, genetic 
disorders (e.g., cystic fibrosis), and birth defects (Preston and Hoffmann, 2001; Rogers 
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and Kavlock, 2001).  Chromosomal alteration of tumor-suppressor genes and proto-
oncogenes has been associated with many cancers and is recognized as a possible 
initiating step in the three-stage model of carcinogenesis.  Although carcinogenesis is a 
complex process, an association between mutagenicity and carcinogenicity has been 
demonstrated for many chemicals, including some PAHs (Preston and Hoffmann, 
2001). 
The in vitro genotoxicity of individual PAHs, especially BaP, has been studied 
extensively.  ATSDR (1995b) has summarized studies of PAH in vitro genotoxicity.  
Several PAHs caused gene mutations in strains of Salmonella typhimurium and DNA 
damage in Escherichia coli.  BaP caused a wide range of genotoxic effects in cultured 
mammalian cells, including gene mutations (mouse, hamster and rat), chromosome 
aberrations (hamster, mouse, rat), sister chromatic exchange (hamster, rat), 
transformation (hamster, mouse, rat), and DNA binding (chick embryo, hamster, mouse, 
rat).  BaP was also genotoxic in cultured human cells, causing gene mutations, 
chromosome aberrations, sister chromatid exchange, unscheduled DNA synthesis, and 
DNA binding in various cell types, including lymphocytes, lymphoblasts, skin fibroblasts, 
keratinocytes, bladder, endometrial, colon and bronchus cells (ATSDR, 1995b).  BaP 
induced DNA adducts at key mutational hotspots in the tumor-suppressor gene P53 in 
human HeLa and bronchial epithelial cells (Denissenko et al., 1996). 
Several complex PAH mixtures are also genotoxic in vitro.  PAH-rich fractions of 
coal tar, wood preserving waste, and manufactured gas plant residue produced positive 
results in microbial genotoxicity bioassays (Cizmas et al., 2004a; Cizmas et al., 2004b; 
Mayura et al., 1999).  Extracts from diesel particle emissions induced DNA adducts in 
the human mammary carcinoma cell line MCF-7 (Kuljukka-Rabb et al., 2001).  Extracts 
from gasoline and diesel particle emissions induced DNA adducts in the human 
bronchial epithelial cell line BEAS-2B (Pohjola et al., 2003).  Extractable organic matter 
from ambient air caused DNA breakage in the human-derived cell lines HepG2 and 
Caco-2 (Lazarova and Slamenova, 2004). 
PAHs exhibit genotoxicity in laboratory mammals in vivo.  When applied to 
mouse skin, benzo[b]fluoranthene, benzo[k]fluoranthene and indeno[1,2,3-cd]pyrene 
induced DNA adducts (ATSDR, 1995b).  Treatment of Chinese hamsters with various 
PAHs by intraperitoneal injection resulted in chromosome aberrations (from 
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benz[a]anthracene and BaP) and sister chromatid exchange (from BaP, chrysene and 
dibenz[a,h]anthracene) in bone marrow cells (ATSDR, 1995b).  When administered to 
laboratory mammals, BaP has induced mutations, DNA single strand breaks, 
chromosome aberrations, sister chromatid exchange, and micronuclei (ATSDR, 1995b).  
BaP administered by oral gavage to female ICR mice induced DNA adducts in lung, 
liver, kidney, spleen, and white blood cells (Reddy and Randerath, 1990).  Multiple 
intraperitoneal injections of BaP induced DNA adducts in lung, liver, spleen and 
peripheral blood mononuclear cells of male Sprague-Dawley rats (Qu and Stacey, 
1996).  Many studies also demonstrate that in vivo treatment of experimental animals 
with PAH-rich mixtures such as coal tar, wood preserving waste, manufactured gas 
plant residues and cigarette smoke condensate induces PAH-DNA adducts in multiple 
tissues (Cizmas et al., 2004b; Randerath et al., 1996; Randerath et al., 1994; Reddy 
and Randerath, 1990; Weyand and Wu, 1995). 
Human exposure to PAH mixtures has been linked to increased levels of PAH-
DNA adducts (Kriek et al., 1998).  PAH-DNA adduct levels in white blood cells of coke-
oven workers correlated to estimated occupational exposure level (Ovrebo et al., 1992).  
A meta-analysis of occupational DNA adduct studies demonstrated a significant 
association between DNA adduct levels and air pollution exposure in industrial and 
urban workers and also found a correlation between measured BaP air concentrations 
and DNA adduct levels (Peluso et al., 2001).  However, in other studies summarized by 
ATSDR (1995b), the dose-response relationship between PAH and/or BaP exposure 
levels and genotoxic effects was not significant. 
1.3.4.2 Carcinogenicity in Animals 
Some of the earliest evidence of PAH carcinogenicity was obtained in the early 
twentieth century by K. Yamagiwa and H. Tsutsui who generated malignant skin tumors 
in rabbits and mice, respectively, by repeatedly applying coal tar to the skin of the 
animals (Phillips, 1983).  However, it was not then known that PAHs in the coal tar were 
causative agents.  In the 1920s and 1930s, E.L. Kennaway and his colleagues studied 
coal tar intensively, hypothesized that PAHs were the primary carcinogenic agents in 
coal tar, and proved the carcinogenicity of PAHs by demonstrating that several pure, 
chemically synthesized PAH compounds produced skin tumors in mice (Phillips, 1983).  
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Kennaway’s group eventually isolated benzo[a]pyrene (BaP) from coal tar and found 
both the isolated BaP and synthetic BaP to be highly carcinogenic (Cook et al., 1933). 
Largely based on evidence of carcinogenicity in experimental animals, seven 
PAHs have been classified as probable human (B2) carcinogens.  These seven 
carcinogenic PAHs are listed in Table 1-2 with the abbreviations that will be used in this 
text.  The compounds are listed in order of decreasing toxic equivalency factor (TEF) 
proposed by Nisbet and LaGoy (1992).  TEFs are used in risk assessment to relate the 
toxicity of compounds that have similar chemical structures and modes of action to a 
reference compound.  The carcinogenicity of selected PAHs was assessed relative to 
reference compound BaP, which was assigned a TEF of 1.0. 
 
Table 1-2 
Toxic equivalency factors (TEFs) for carcinogenic PAHs  
Compound Abbreviation TEF a 
Dibenz[a,h]anthracene DBA 5 
Benzo[a]pyrene BaP 1 
Benz[a]anthracene BaA 0.1 
Benzo[b]fluoranthene BbF 0.1 
Benzo[k]fluoranthene BkF 0.1 
Indeno[1,2,3-cd]pyrene IDP 0.1 
Chrysene Chr 0.01 
a. TEFs from Nisbet and LaGoy (1992)  
 
 
BaP has been widely studied and its toxicity is the most well-characterized of the 
PAHs.  BaP has been associated with an increased incidence of tumors in multiple 
rodent studies; tumor locations vary with administration route and include upper 
respiratory tract, digestive tract, skin, and injection sites (USEPA, 1994b).  In two similar 
studies, three consecutive doses of BaP administered by intraperitoneal injection to 
newborn CD-1 mice resulted in statistically significant increases of incidence of liver 
tumors in males, and lung tumors in both males and females (Lavoie et al., 1987; 
Wislocki et al., 1986).  In a 2-year feeding study of female B6C3F1 mice, 3 dose levels 
of BaP were administered (Culp et al., 1998).  Percentage survival was significantly 
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reduced in the medium- and high-dose groups.  The incidence of papillomas and 
carcinomas of the forestomach, esophagus and tongue was significantly higher in BaP-
treated groups and a significant dose-related effect was observed in each of these 
tissues (Culp et al., 1998).  
Dibenz[a,h]anthracene (DBA) has the highest TEF (5.0) of the PAH B2 
carcinogens.  DBA administered in drinking water to DBA/2 mice induced pulmonary 
adenomas, pulmonary carcinomas, and mammary carcinomas (USEPA, 1994f).  
Gavage administration (2 doses per week, 15 weeks) of DBA to pseudo-pregnant 
female Balb/c mice resulted in mammary carcinomas in 13 out of 24 mice versus 2 out 
of 30 in the untreated control group (USEPA, 1994f).  In a study designed to test skin 
tumor-initiating activity of various carcinogens, female Sencar mice received a single 
dermal application of DBA followed by 15 weeks of twice-weekly application of a 
promoting agent.  At the end of treatment, papillomas were observed in 50% of treated 
mice (versus 6% control) at an average of 1.4 papillomas per mouse (Slaga et al., 
1980).  Subcutaneous injection of DBA (20 doses, 3 per week) induced injection-site 
sarcomas in 100% of female S-D rats versus 0% incidence in both the untreated and 
vehicle-treated control groups (Flesher et al., 2002). 
Benz[a]anthracene (BaA) caused increased incidence of tumors at 
administration sites in mice exposed to BaA by gavage, subcutaneous injection and 
topical application (USEPA, 1994a).  Repeated gavage with a solution containing 3% 
BaA caused an increased incidence of hepatomas and pulmonary adenomas in male 
B6AF1/J mice (Klein, 1963).  In another study, newborn CD-1 mice were administered 
three doses of BaA by IP injection between birth and 15 days of age; survivors were 
sacrificed after 1 year.  Statistically significant increases in tumor incidence occurred in 
both males (liver) and females (lung) (Wislocki et al., 1986). 
Benzo[b]fluoranthene (BbF), benzo[k]fluoranthene (BkF), and indeno[1,2,3-
cd]pyrene (IDP) all contain a five-membered ring and have each been assigned a 0.1 
TEF value.  BbF, BkF and IDP have all generated positive results for tumor initiation in 
mouse skin painting assays (USEPA, 1994c; USEPA, 1994d; USEPA, 1994g).  In a 
lifetime lung-implantation study of 3-month-old female Osborne-Mendel rats, tumors in 
the lung and thorax (epidermoid carcinomas and pleomorphic sarcomas) were induced 
in a dose-dependent manner by BbF, BkF and IDP.  The percentage of animals 
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showing a response (tumor formation) was 37% for BbF, 44% for BkF, and 60% for 
IDP, versus 0% for both untreated and vehicle-treated animals (Deutsch-Wenzel et al., 
1983).  In another study, BbF, BkF, and IDP were administered in three consecutive 
doses by intraperitoneal injection to newborn CD-1 mice (Lavoie et al., 1987).  The mice 
were sacrificed after 52 weeks and the number of mice with liver or lung tumors was 
determined.  BbF induced liver tumors in 8 out of 15 male mice (p < 0.005) and lung 
tumors in 2 of the male mice.  BkF induced liver tumors in 3 out of 16 male mice, lung 
tumors in 1 out of 16 male mice and 3 out of 18 female mice, but these results were not 
statistically significant.  IDP was not tumorigenic in this study (Lavoie et al., 1987). 
Chrysene (Chr) has the lowest TEF (0.01) of the PAH B2 carcinogens.  In skin 
painting assays for initiating activity, Chr produced positive results in several mouse 
strains when applied in combination with various promoting agents (USEPA, 1994e).  
For example, dermal application of Chr to female Sencar mice resulted in papillomas in 
73% of treated mice (versus 10% control) at an average of 1.6 papillomas per mouse 
(Slaga et al., 1980).  In another study, newborn CD-1 mice were administered either a 
low (700 nmol) or high (2800 nmol) dose of Chr three times by IP injection between 
birth and 15 days of age; survivors were sacrificed after 1 year (Wislocki et al., 1986).  
In males of the low-dose group, statistically significant increases in incidence of liver 
tumors and malignant lymphoma were observed.  In males of the high-dose group, 
statistically significant increases in incidence of liver tumors and lung tumors occurred.  
In females, no differences were observed between either dose group and controls 
(Wislocki et al., 1986). 
1.3.4.3 Carcinogenicity in Humans 
PAHs do not occur in the environment as individual compounds, but rather as 
mixtures of many PAH compounds.  In addition, humans are usually exposed to PAHs 
which are part of complex chemical mixtures, such as tobacco smoke, containing other 
carcinogens.  Because of this, when a complex chemical mixture is found to cause 
cancer in humans, establishing PAHs as the carcinogenic agents is difficult.  Most 
evidence of PAH mixture carcinogenicity comes from occupational studies in which 
workers involved in coal gasification, coke production, roofing, or oil refining were 
exposed to PAH-rich mixtures (ATSDR, 1995b). 
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The 1775 report of Percival Pott on the role of soot exposure in the incidence of 
scrotal cancer among chimney sweeps is widely recognized as the first documentation 
of carcinogenicity of a mixture containing PAHs (Gallo, 2001).  In a review summarizing 
fifty years of research on BaP, D.H. Phillips (1983) noted that, in the nineteenth century, 
workers in the coal tar, paraffin refining and shale oil industries were known to 
experience high incidences of skin cancer, although the causative agents were not 
identified.   
A large, long-term epidemiological study of steelworkers in Allegheny County, 
Pennsylvania examined cancer morbidity and mortality rates of workers in the coke 
production areas relative to workers in all other areas of the steel plants.  Increased 
rates of respiratory cancer were observed among coke oven workers (Lloyd, 1971).  
Excess mortality from lung and kidney cancer was documented among coke oven 
workers and digestive system cancers were significantly elevated in non-oven workers 
in the coke production areas (Redmond et al., 1976).  In addition, evidence was found 
of a consistent dose-response relationship between lung cancer mortality and estimated 
cumulative exposure to coal tar pitch volatiles (Redmond, 1983). 
Mastrangelo et al. (1996) reviewed 10 epidemiological studies of occupational 
PAH exposure published between 1979 and 1995.  Occupations included were iron 
foundry worker, aluminum factory worker, miner, and steelworker.  Other population-
based studies included various occupations, and a population in an area with high 
density of chemical plants.  Studies were chosen which described PAH exposure in 
quantitative or qualitative levels and which examined cancer as an endpoint.  The 
authors concluded that risks of lung and bladder cancer from PAH exposure were dose-
dependent (Mastrangelo et al., 1996). 
Boffetta et al. (1997) reviewed cancer risk from occupational and environmental 
exposure to PAHs, with evidence from more than a dozen industries and occupations.  
The authors found that heavy occupational exposure to PAH mixtures increases the risk 
of lung, skin, or bladder cancer.  Lung cancer risk was increased among most of the 
occupations.  Skin cancer increased in occupations in which dermal exposure was 
substantial.  High exposure to coal tar and pitch, such as among workers in aluminum 
production, coal gasification and tar distillation, was associated with increased bladder 
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cancer risk.  There was also limited evidence of a possible link between kidney cancer 
and occupational PAH exposure (Boffetta et al., 1997). 
A recent review (Bosetti et al., 2007) examined epidemiological cohort studies of 
workers exposed to PAHs which were published up until December, 2005, mainly those 
published after the studies covered in Boffetta et al. (1997).  The review focused on risk 
of cancers of the respiratory and urinary tracts and included studies of workers in 
industries of aluminum production, coal gasification, coke production, iron and steel 
foundry, coal tar and related products, carbon black and carbon electrodes production.  
Increased risks from lung and bladder cancer were found in some of these occupations.  
The authors mention that data are limited from several of the industries, and estimation 
of exposure and effects of confounding factors and exposures other than PAHs 
continue to complicate the interpretation of the data.  Dose-risk relationships were found 
in coke production workers (lung cancer) and iron and steel foundry workers 
(respiratory tract cancers), but effects of exposure to other potentially carcinogenic 
substances could not be isolated.  Overall, the authors concluded that epidemiological 
evidence confirms an excess lung cancer risk in several PAH-related industries and an 
excess risk of urinary system cancers in aluminum production, coal gasification, and 
iron and steel foundry workers (Bosetti et al., 2007).  
The relationship between PAH exposure and incidence of bladder cancer was 
examined in a large historical cohort (7298 men) of asphalt pavers in Denmark, Norway, 
Finland and Israel (Burstyn et al., 2007).  A detailed procedure was used to estimate 
cumulative and average PAH exposure of each member of the cohort.  Inhalation 
exposure levels were modeled for different paving operations and technologies based 
on previously available personal exposure measurements from asphalt industry 
workers.  By coupling the detailed job history and the modeled exposure levels, the 
authors reconstructed an exposure history for each cohort member.  Members were 
then divided in exposure quartiles.  Cumulative exposure was not associated with risk of 
bladder cancer; the two higher quartiles of average exposure had approximately 40% 
excess risk of bladder cancer but there was no dose-response trend.  When a 15-year 
lag was factored into the average exposure, there was a twofold increase in bladder 
cancer risk in the two higher average exposure quartiles.  The work histories for 
subjects only included the time that each was employed in asphalt paving, and thus 
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could not control for PAH exposure in other occupations and lifestyle exposures (such 
as smoking).  Also, dermal PAH exposure, which might be significant, was not 
estimated.  The authors concluded that 1) work in asphalt paving may be associated 
with increased risk of bladder cancer, 2) exposure to relatively low airborne PAH levels 
may confer risk of bladder cancer, and 3) inability to control for sources of confounding 
and bias, lack of exposure-response trend, and borderline statistical significance of the 
data hampered interpretation of study results (Burstyn et al., 2007). 
A nested case-control study examined association of prostate cancer incidence 
with occupational chemical exposure in workers at a nuclear energy and rocket engine-
testing facility (Krishnadasan et al., 2007).  A job exposure matrix was used to estimate 
occupational exposures to PAHs, benzene, mineral oil, hydrazine, and 
trichloroethylene.  High levels of trichloroethylene exposure were associated with 
prostate cancer incidence.  Increased risk of prostate cancer was observed at high 
levels of PAH exposure, but when the data were adjusted for other chemical exposures 
(PAH exposure was highly correlated with benzene and trichloroethylene exposures), 
only a weak association of PAH exposure with prostate cancer incidence was found.  
The authors note that PAH exposure levels among the workers in the study were likely 
lower than those in studies in which a strong association between PAH exposure and 
prostate cancer was found (Krishnadasan et al., 2007). 
Another epidemiological study compared the use of two PAH exposure indices 
in aluminum smelter workers exposed to coal tar-derived substances (Friesen et al., 
2007).  The indices were cumulative exposure to BaP and cumulative exposure to 
benzene-soluble material (BSM).  A job exposure matrix was developed from routine 
measurements of BaP and BSM at the facility, and the matrix was applied to each 
worker’s job history to obtain cumulative exposure indices for each worker. The health 
outcomes evaluated were bladder cancer incidence, lung cancer incidence, and 
mortality due to acute myocardial infarction.  Both exposure indices were strongly 
associated with bladder and lung cancer incidence and modestly associated with 
mortality due to acute myocardial infarction.  The exposure-response model precision 
for cancer incidence was somewhat better with the BaP exposure index than the BSM 
exposure index (Friesen et al., 2007). 
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1.3.4.4 Immunotoxicity 
Compromised immune system functioning increases susceptibility to bacterial 
and viral infections and may result in repeated, more severe, or longer infections.  The 
immune system also plays a role in identification and rejection of neoplasms, and thus 
in the development of cancer.  PAHs are known to be potent immunosuppressants 
which have effects on humoral immunity, cell-mediated immunity, and host resistance 
(Burns-Naas et al., 2001). 
Most evidence of the immunotoxicity of PAHs is from lab animal studies and a 
few human cell culture studies.  When applied to mouse skin, BaP suppressed humoral 
and cell-mediated immunity, and onset of skin tumors was accompanied by changes in 
Langerhans cell number, distribution, and morphology (ATSDR, 1995b).  In utero 
exposure of mice to a single dose of BaP by intraperitoneal injection reduced specific T 
cell subsets in the thymus and spleen, and resulted in severe and sustained 
immunosuppression and an increase in tumor incidence later in life (Rodriguez et al., 
1999; Urso and Gengozian, 1980; Urso and Gengozian, 1984; Urso and Johnson, 
1987).  In rats, oral administration of fluoranthene caused significant decreases in white 
blood cell counts in both acute and subchronic studies (Knuckles et al., 2004).  
Subchronic oral administration of BaP to rats resulted in immunotoxicity as measured 
by several parameters, including thymus and lymph node weights, and counts of spleen 
B cells, spleen natural killer cells, red blood cells, white blood cells, lymphocytes, and 
granulate eosinophils (De Jong et al., 1999). 
Isolated mouse splenic macrophages were capable of metabolizing BaP in vitro 
(Ladics et al., 1992b), and repeated subcutaneous injections of BaP altered the 
macrophage cell population, suggesting that macrophages are a target of BaP (Ladics 
et al., 1992a).  PAHs inhibited activation of human and rodent B and T lymphocytes and 
suppressed mitogenesis of human peripheral blood T cells in vitro (Davila et al., 1996; 
Romero et al., 1997).  In human peripheral blood mononuclear cell lymphocytes, BaP 
did not deplete glutathione, but reactive BaP metabolites did (Romero et al., 1997). 
The influence of CYP enzymes on BaP immunotoxicity was investigated in 
short-term feeding studies of C57BL/6J mice and several knockout strains (Uno et al., 
2004; Uno et al., 2006).  In the wild-type animals, 18 days of a diet of food soaked with 
corn oil containing BaP resulted in a decrease in thymus weight.  Relative to untreated 
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controls and treated wild-type mice, BaP-treated Cyp1a1 knockout mice had extreme 
bone marrow hypocellularity and a marked decrease in blood lymphocytes, spleen 
weight and thymus weight (Uno et al., 2004).  Thymus and spleen weights were also 
significantly decreased in BaP-treated Cyp1a1/Cyp1b1 knockout mice.  The authors 
concluded that inducible CYP1A1 is more important in detoxification than activation of 
ingested BaP and that “CYP1B1 in spleen and in bone marrow seems to be responsible 
for metabolic activation of benzo[a]pyrene, which results in immune damage in the 
genetic absence of CYP1A1” (Uno et al., 2006). 
1.3.4.5 Metabolic Activation 
PAHs are generally not toxic in their unsubstituted form; they must be 
transformed into toxic metabolites by cellular XMEs.  However, because PAHs enter 
cells easily and rapidly partition into cytoplasmic membranes (Barhoumi et al., 2000), 
metabolism is also required to make the molecules more water soluble so that they can 
be excreted from the cell.  Therefore, cellular XMEs are critical to both the bioactivation 
and detoxification of PAHs. 
Unsubstituted PAHs are similar in structure and undergo similar pathways of 
metabolism.  The metabolism of BaP is the most fully characterized of all the PAHs and 
is described here in Fig. 1-5, which was adapted from Ramesh et al. (2004) and 
Shimada (2006).  The first step in BaP metabolism is transformation by CYP into either 
phenols or epoxides.  Phenols may be further metabolized to quinones, and epoxides 
may be further metabolized to phenols or by epoxide hydrolase (EH) to dihydrodiols.  
From dihydrodiols, phenol diols are formed, as well as diol epoxides (catalyzed by CYP) 
and quinones which are formed by the action of aldo-keto reductase (AKR).  Diol 
epoxides can undergo further transformation by EH to tetraols.  At each step along 
these pathways, oxygenated metabolites may be detoxified by conjugation catalyzed by 
phase II XMEs such as GST, UGT, and sulfotransferases (SULT).  The conjugates are 
then excreted from the cell and eliminated from the body by renal or biliary routes 
(Ramesh et al., 2004; Shimada, 2006). 
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Fig. 1-5. BaP metabolic pathways. CYP = cytochrome P450; EH = epoxide hydrolase; 
AKR = aldo-keto reductase; Conj = conjugated metabolite. Adapted from Ramesh et al. 
(2004) and Shimada (2006). 
 
 
When PAHs were isolated and identified as carcinogens, it was thought that the 
parent compounds themselves were biologically active; metabolism was considered to 
be solely a detoxification process (Phillips, 1983).  The possibility that PAH metabolites 
were biologically active was proposed by Boyland in 1950 (Boyland, 1950).  Evidence 
accumulated during the 1960s that covalent binding of PAHs to DNA was a critical step 
in carcinogenesis (Phillips, 1983).  In the late 1960s, Gelboin (1969) and Grover and 
Sims (1968) demonstrated in in vitro systems that PAHs would bind to DNA only in the 
presence of induced rat liver microsomal fractions.  Further study of PAH metabolism 
and DNA binding suggested that BaP-7,8-dihydrodiol had 10 times the DNA binding 
affinity of the parent compound (Borgen et al., 1973) and that further metabolism of the 
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dihydrodiol produced BaP-7,8-diol-9,10-epoxide (BPDE), the ultimate carcinogen (Sims 
et al., 1974). 
Based on these discoveries, the theory of the bay region dihydrodiol epoxide 
metabolic pathway was developed and was considered to be the dominant mechanism 
for bioactivation of carcinogenic PAHs.  The bay region is a deep pocket that exists 
where a single benzene ring is attached to an angular ring fusion (Fig. 1-6).  The 
formation of a bay region diol epoxide proceeds through three steps (Fig. 1-7).  Step 1 
is CYP-catalyzed oxidation of a double bond on the single-fused ring to an unstable 
arene oxide (epoxide).  In Step 2, epoxide hydrolase (EH) hydrolyzes the arene oxide to 
a dihydrodiol.  Step 3 is another CYP-catalyzed oxidation, this time of the double bond 
adjacent to the bay region, which forms a bay region diol-epoxide.  Several PAHs are 
metabolized through this pathway, including BaP, chrysene, 5-methylchrysene, 
phenanthrene, benzo[c]phenanthrene, benz[a]anthracene, 7,12-
dimethylbenz[a]anthracene, and dibenzo[a,l]pyrene (Xue and Warshawsky, 2005).   
When the bay region epoxide opens, a benzyl cation forms which is stabilized by 
the aromatic bonds around the bay region.  This benzyl cation is a highly reactive 
electrophile which binds covalently to cellular macromolecules, including DNA.  The 
most common binding sites of PAH-diol-epoxide DNA adducts are the exocyclic amino 
groups of deoxyguanosine (dG) and deoxyadenosine (dA) (Xue and Warshawsky, 
2005).  The major DNA adduct of BPDE, the bay region diol-epoxide of BaP, is formed 
by bonding of the C10 of BPDE to the N2 of dG (Cheng et al., 1989). 
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Fig. 1-6. Representative PAHs with bay regions. 
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Fig. 1-7. Bioactivation of BaP by bay region dihydrodiol epoxide metabolic pathway. 
 
 
 
Another important pathway of PAH activation is through generation of reactive 
and redox active PAH-ortho-quinones.  Once the PAH-dihydrodiol is formed by the 
combined action of CYP and EH, another set of enzymes, the dihydrodiol 
dehydrogenases, compete with CYP to transform the dihydrodiol.  Enzymes of the AKR 
superfamily are responsible for human dihydrodiol dehydrogenase activity.  AKR 
enzymes oxidize PAH dihydrodiols to unstable catechols as shown in Fig. 1-8 (adapted 
from Penning et al. (1999)).  The catechol undergoes autoxidation in the presence of 
oxygen.  In the first oxidation, peroxide and an o-semiquinone anion radical are formed.  
In the second oxidation, superoxide anion and an o-quinone are formed.  The o-quinone 
can then undergo nonenzymatic reduction to either the catechol or the o-semiquinone 
anion radical, setting up redox cycling which can amplify generation of reactive oxygen 
species (ROS), such as peroxide and superoxide anion, all resulting from oxidation of a 
single molecule of PAH-dihydrodiol by AKR (Penning et al., 1999). 
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Fig. 1-8. Bioactivation of PAH by o-quinone pathway. Adapted from Penning et al. 
(1999). 
 
 
PAH-o-quinones can react with DNA to form both stable and unstable 
(depurinating) adducts in vitro.  Acellular assays have demonstrated that quinones of 
BaP (Balu et al., 2004; McCoull et al., 1999; Shou et al., 1993), naphthalene (McCoull 
et al., 1999), and phenanthrene (McCoull et al., 1999) covalently bond to DNA 
nucleosides.  ROS can induce oxidative damage of DNA bases, forming oxidized 
deoxynucleosides that can cause base mismatching and result in gene mutations (Xue 
and Warshawsky, 2005).  In both these ways, the oxidation of PAH-dihydrodiols by AKR 
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can lead to DNA damage which contributes to the genotoxicity of PAHs.  In addition, 
ROS are known mitogens which enhance tumor promotion. 
  
1.4 Analysis of Environmental Mixtures 
The goal of human health risk characterization is to determine the change in risk 
of adverse health effects for a population of humans caused by their exposure to 
environmental contaminants.  Toxicity assessment is an essential component of human 
health risk characterization.  The outcome of toxicity assessment is a quantitative 
expression of the exposure-effect relationship.  The most biologically relevant human 
toxicity assessment for an environmental mixture would be based on the evaluation of 
actual health effects in an existing exposed human population.  Where this is not 
feasible or desirable (which is almost always the case), a variety of analysis methods 
may be used to assess the toxicity of an environmental mixture.  These methods range 
from chemical analysis to toxicity testing models to complex epidemiological studies.  
Mixture analysis methods vary in consumption of resources (duration, size, cost), ease 
of data interpretation (specificity of effects, mechanistic information, statistical power), 
and relevance of the results to actual human biological responses and exposure 
conditions.  Ultimately, interpretation of the combined results from multiple analysis 
methods will provide the most complete characterization of the human health risk of an 
environmental mixture. 
1.4.1 Chemical Analysis 
The chemical analysis approach to toxicity assessment of environmental 
mixtures involves determining the individual chemical components of the mixture and 
estimating the toxicity of the mixture based on the toxicity of individual components.  In 
general, for chemical analysis of mixtures of hydrocarbons, a sample of the 
environmental medium contaminated with the mixture is collected, components of the 
mixture are extracted from the environmental medium, and the components of the 
extract are identified and quantified by analytical instrumentation.  This approach relies 
on the availability of toxicity assessments for each mixture component and assumptions 
of how the toxicity of each component affects the rest of the mixture.  For example, the 
toxicity of PAHs is usually considered to be additive, so the toxicity of each PAH is 
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weighted by its concentration in the mixture, and the sum of these weighted toxicities is 
determined to be the overall toxicity of the PAH mixture. 
The resource consumption of chemical analysis is relatively low compared to 
other mixture toxicity analysis methods.  It includes planning and execution of field 
sampling, processing of samples (transportation, tracking, preparation for analysis), 
analysis and quantitation.  Analytical equipment is costly but is usually shared by many 
projects.  Results are obtained quickly compared to animal or epidemiological studies.  
The low resource consumption often allows analysis of many samples, which increases 
statistical power.  Data interpretation is relatively easy if toxicity data and interaction 
information are available for each component, but this is rarely the case.  Because 
chemical analysis does not directly measure toxicity, the relevance of results of 
chemical analysis to actual human exposures and biological effects is low unless 
extensive information is available about how humans are exposed, the component 
toxicities, and the mixture interactions.  In addition, environmental matrices can be 
highly heterogeneous with significant temporal and spatial variability; sometimes many 
samples must be collected in order to accurately represent the contamination level and 
potential for exposure. 
1.4.1.1 PAH Analysis by Gas Chromatography/Mass Spectrometry 
USEPA Method 8270, “Semivolatile Organic Compounds by Gas 
Chromatography/Mass Spectrometry” is an approved method for analyzing PAH 
concentrations in extracts from many types of solid waste matrices, soils, air sampling 
media and water samples (USEPA, 1996).  Extracts may be prepared by various 
methods, including Soxhlet extraction, ultrasonic extraction, and pressurized fluid 
extraction (method used in this research).  The prepared sample extracts are mixed 
with a carrier gas, heated to high temperature, and injected into a capillary column gas 
chromatograph (GC) for separation.  A computer-controlled program gradually 
increases the capillary column temperature to better separate the analytes of complex 
mixtures with a range of boiling points.  Analytes eluted from the GC then enter a mass 
spectrometer (MS) for detection.  The MS fragments the analytes into gas-phase ions, 
separates these ions by mass-to-charge ratio, and measures the quantity of ions of 
each mass-to-charge ratio.  Each PAH analyte has a unique fragmentation “fingerprint” 
 38 
that can be detected by the MS.  Analyte concentrations are quantitated by comparing 
the fragmentation spectra detected to a database of known spectra. 
1.4.2 Mammalian Cell Culture 
Mammalian cells can be isolated and grown in culture for use in toxicity testing.  
Cultured cells offer many advantages as toxicity testing models for environmental 
mixtures.  Consumption of resources is low relative to other toxicity analysis methods.  
Cultured cells grow rapidly, allowing generation of large amounts of cells and many 
experimental groups.  Cells can be frozen and stored for future use, allowing flexibility in 
planning of experiments.  Because cells are small and experiments short, the costs of 
cell-based experiments are relatively low.  The combination of cell culture models with 
powerful imaging techniques enables the collection of real-time data.  The conditions 
under which cells are grown can be tightly controlled, minimizing variations in results 
and increasing statistical power.  The genetic homogeneity of cell lines further reduces 
experimental variability, decreases the number of replications needed, and eases 
interpretation of results.  An environmental mixture can be applied directly into the 
culture medium, reaching the cells almost immediately, so that cellular responses occur 
quickly and the dose is well controlled.  Cell culture is preferred to live animal testing for 
ethical reasons.  Because of these advantages, many assays have been developed for 
evaluating toxicity in cultured cells. 
One other important advantage of cultured cells is that techniques have been 
developed that make genetic modification of cells relatively simple.  Modification of 
mammalian cells by introduction of various gene clones can enhance the utility of the 
cell line in toxicity research.  For example, transgenic HepG2 cells containing the entire 
human pregnane X receptor (hPXR) gene have been used to assess the ability of 
pesticides to induce CYP3A4 and CYP2B6 (Lemaire et al., 2004).  Cultured mammalian 
cells can also be used to study the mechanisms of toxicity and to characterize dose-
response relationships. 
The disadvantages of mammalian cell culture for toxicity analysis are related to 
the relevance of the results to humans.  Results of cell culture studies cannot be 
extrapolated directly to human toxicity assessment because of many factors, including 
the lack of tissue interactions and the highly simplified toxicokinetics of cells in culture 
(Combes, 2005).  Chemicals are usually administered at a certain concentration in the 
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cell growth medium rather than in a measured amount, so dose determination is 
difficult.  Gene expression in cultured cells may be different from the intact animal; this 
has resulted in major differences in the effects of gene expression on toxicity between 
cultured cells and whole animals (Nebert, 2006).  It is difficult to relate the doses 
administered in cell culture to actual human exposures.  Cellular responses to challenge 
with a xenobiotic may be easily measured, but extrapolating these responses to 
clinically-relevant, whole-organism health effects is a daunting task. 
1.4.2.1 HepG2 Human Cell Line 
Most cultured cells die after a finite number of divisions, but some cells, 
commonly those derived from tumors, have the ability to divide indefinitely and are 
developed into immortalized cell lines.  Many mammalian cell lines have been utilized 
as toxicity testing models.  These cell lines include those derived from mice (embryonic 
fibroblast 3T3, hepatoma Hepa1c1c7, lymphoma L5178Y), rats (liver epithelial Clone 9), 
hamsters (ovarian epithelial CHO, fibroblast BHK21), dogs (kidney epithelial MDCK) 
and humans (cervical epithelial HeLa, hepatocarcinoma HepG2, breast 
adenocarcinoma MCF-7). 
The laboratory-based research described in this dissertation utilized the widely-
used HepG2 cell line as a model for in vitro analysis of BaP genotoxicity.  HepG2 is a 
human-derived hepatoma cell line that was isolated from a primary hepatocellular 
carcinoma in a young individual by Aden et al. (1979).  HepG2 cells resemble liver 
parenchymal cells and, unlike most mammalian cell lines, have retained functionality of 
many phase I and phase II drug-metabolizing enzymes that are important in 
bioactivation and detoxification of xenobiotics (Knasmuller et al., 1998).  Although 
activities of many enzymes in HepG2 cells are much lower than in primary human 
hepatocytes, substrate specificities are similar (Knasmuller et al., 1998; Rodriguez-
Antona et al., 2002).  In a review of the use of HepG2 cells in genotoxicity studies, 
Knasmuller et al. (2004) concluded that HepG2 cells are a suitable tool for genotoxicity 
testing and that the cell line is highly sensitive towards PAHs.  HepG2 cells have been 
used to evaluate the genotoxic effects of PAHs with many DNA damage assays, 
including SCGE, micronucleus, unscheduled DNA synthesis, sister-chromatid 
exchange, and DNA adduct assays (Cherng et al., 2006; Knasmuller et al., 1998; Staal 
et al., 2006). 
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1.4.2.2  DNA 32P-Postlabeling Assay 
DNA adducts are important indicators of DNA damage and biomarkers of 
exposure to environmental carcinogens (Phillips, 2005).  DNA adducts have been used 
as biomarkers of PAH exposure in environmental toxicology studies of both humans 
(Kriek et al., 1998) and wildlife (Shugart, 2000).  DNA adducts form when genotoxins 
covalently bind with DNA.  Many environmental contaminants are known to cause DNA 
adducts.  Adducts can cause DNA damage which may lead to mutations if the DNA is 
replicated before being repaired.  The formation and persistence of carcinogen-DNA 
adducts have been shown to be critical events for the initiation of chemical 
carcinogenesis in target cells. 
Several methods are available for detecting DNA adducts.  These include 
immunoassays and immunohistochemistry, fluorescence and phosphorescence 
spectroscopy, GC/MS, 32P-postlabeling, and accelerator mass spectrometry (AMS) 
(Poirier et al., 2000).  AMS is the most sensitive method, with a detection limit in the 
range of 1 in 1012 nucleotides, but requires administration of radiolabeled compound 
(Poirier et al., 2000). 
The 32P-postlabeling assay is a highly sensitive and widely used method of 
detecting adducts that was developed in the early 1980s (Gupta et al., 1982).  An 
enhanced procedure published a few years later (Reddy and Randerath, 1986) 
increased the sensitivity of the assay.  The method is capable of detecting adducts at 
frequencies as low as 1 in 1010 nucleotides using 10 µg DNA (Phillips and Arlt, 2007).  
32P-postlabeling can detect a wide range of adducts and does not require knowledge of 
adduct structure, allowing detection of unidentified carcinogens (Randerath and 
Randerath, 1994).  This makes the method ideal for use in studies of exposures to 
environmental mixtures.  In addition to sensitivity and broad applicability, a significant 
advantage of the 32P-postlabeling method is that the DNA is radiolabeled after the 
sample is collected; it is a non-invasive technique that allows retrospective studies and 
eliminates radiation exposure of study participants.  An important limitation of the 32P-
postlabeling method is that although it generates quantitative results, the efficiency of 
adduct labeling is uncertain.  Caution must be exercised when adduct levels are 
compared between experiments.  However, use of a synthetic standard for a specific 
adduct allows the efficiency of labeling to be determined (Phillips and Arlt, 2007). 
 41 
In the 32P-postlabeling assay, digested DNA nucleotides are incubated with [-
32P]ATP and the radioactive orthophosphate is transferred selectively to adducted 
nucleotides.  After the adducts are separate by three-dimensional thin-layer 
chromatography, the radioactivity is quantified.  The relative amount of adducts is 
indicated by the ratio of radiolabeled nucleotides to total nucleotides (Phillips and Arlt, 
2007; Reddy and Randerath, 1986).  The research presented in this dissertation has 
used the DNA 32P-postlabeling assay to detect DNA lesions in cultured human cells 
treated with BaP and in wild mice exposed to environmental mixtures in situ. 
1.4.3 Laboratory Animals 
The use of laboratory animals as toxicity testing models for environmental 
mixtures offers some of the same advantages as cultured cells.   Like cell culture 
experiments, in laboratory animal experiments the conditions under which the organism 
lives can be tightly controlled.  The administered dose is known and the elapsed time 
between exposure and the measurement of effects is known.  Route of exposure is also 
controlled.  Confounding factors such as diet and age are the same across all 
experimental groups.  In-bred rodent strains developed for laboratory use are 
genetically similar; this homogeneity reduces variability in results and increases 
statistical power. 
The genetics of laboratory animals can also be manipulated, although this is a 
much more complicated and resource-intensive process than in cultured cells.  
Controlled genetic variation in laboratory animals has helped scientists to further 
understanding of molecular biology and to elucidate mechanisms of disease and 
toxicity.  Mouse strains have been developed with naturally-occurring genetic variations 
which generate distinct phenotypes.  For example, important advances in the 
understanding of PAH metabolism were made by comparing mice with a low-affinity 
form of the aryl hydrocarbon receptor (AhR) to those with a high-affinity form 
(Parkinson, 2001).  Key genes may be removed from the genome; this creates a 
”knockout” strain that is useful for studying environmental agents (Nebert and Duffy, 
1997).  Important gene knockout strains for the study of PAHs include AhR, CYP1A1 
and CYP1B1 knockout mice.  Transgenic mouse strains carrying human copies of 
genes have also been developed.  These ”humanized” mouse strains can be especially 
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useful when there are distinct differences between the murine and human genes, such 
as with PXR (Xie et al., 2000). 
An advantage of laboratory animal experiments over cell culture experiments is 
that they are more relevant to humans.  The chemical is administered to the intact 
animal.  Cells are supported by normal tissue architecture and have important cell-cell 
interactions.  Whole animal toxicokinetics are in effect, including partitioning of mixture 
components and the formation of metabolites in one tissue that exert toxic effects in 
another tissue.  Health effects can be assessed at the molecular, cellular, organ, tissue, 
and whole organism levels. 
A disadvantage of laboratory animals relative to cell culture is that animal 
experiments usually are more resource-intensive.  Animals must be cared for humanely 
and in accordance with regulations; animals also take up much more space and cost 
more to purchase.  Because of toxicokinetics, effects often take longer to appear and a 
larger dose is often needed to generate a measurable effect.  Most animal bioassays 
require sacrifice of the animal, whereas many cell culture assays can be performed 
while the cells are still alive. 
Limitations exist to the application of results from laboratory animal toxicity 
testing to human health risk assessment.  Animal studies often employ higher doses 
than are expected in humans and do not have adequate dose-response information for 
extrapolation to lower doses.  Effects may be triggered at high doses that will not occur 
at lower doses.  An example is urinary bladder tumor formation in rats that is caused by 
crystal precipitation of compounds in the bladder because the high dose exceeded the 
solubility of the compounds in urine (Faustman and Omenn, 2001).  Exposures in 
animal experiments are often at discrete intervals, whereas many human exposures to 
environmental mixtures are frequent or nearly constant.  The duration of exposure in 
animal experiments is usually shorter than the duration of typical human environmental 
exposures. 
Significant differences in toxicokinetic processes can exist between 
experimental animals and humans (Kedderis and Lipscomb, 2001); these differences 
can lead to variation in the relationship between the administered dose and the internal 
dose at the target organ.  Some administration methods used in animal studies, such as 
the intraperitoneal injection, do not occur in humans.  The effects of direct oral gavage 
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administration on the rodent forestomach are not relevant for human exposure 
(Faustman and Omenn, 2001); in addition to the stress that the animal undergoes, 
direct gavage does not account for the dilution and interactions of the study compounds 
with food.  Route-to-route extrapolation must take into account the differences in 
contact time and area, absorption rates and metabolism between different tissues.  The 
uptake of contaminants can vary between species; for example, humans may receive 
smaller doses of inhaled contaminants than rats exposed to the same air concentrations 
because the surface area of the human olfactory epithelium is much smaller than that of 
the rat (Frederick et al., 1998).  Metabolic capabilities, and therefore bioactivation 
and/or detoxification, vary between species.  In some cases, different metabolizing 
enzymes are present in animals and humans; inducibility of enzymes may also be 
different between animals and humans (Parkinson, 2001).  Differences in structure and 
function of key receptors also contribute (Barrett, 1995).  Elimination of compounds 
occurs at varying rates and even by different routes in different species.  These 
differences in toxicokinetic processes present a challenge for application of animal 
toxicity data to human health risk assessment.  However, animal-to-human 
extrapolation can be improved by accounting for comparative physiological and 
toxicokinetic parameters. 
1.4.4 Animals in situ 
Animals are exposed to contaminant mixtures in their environments.  Humans 
and animals share local environments, food chains, air and water and thus share the 
potential for exposure to environmental contaminant mixtures.  Animals have been used 
as sentinels for human health risk posed by environmental contaminants for more than 
a century; examples of these uses were compiled by van der Schalie et al. (1999).  In 
several of these uses, animals provided effective early warning of potential risks to 
humans because the animals were more susceptible to the toxins.  The authors 
identified potential applications for sentinel species, including monitoring environmental 
media and identifying new exposures of potential concern (van der Schalie et al., 1999).  
Study of sentinel animals can provide information about contaminant exposures and 
effects that cannot be collected from humans.  For example, tissues from throughout 
the body of an exposed sentinel animal can be analyzed for toxicant levels and effects; 
this is obviously infeasible in humans (O'Brien et al., 1993).  Sentinel animals also are 
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not subject to some confounding factors that occur in humans, such as smoking, 
occupational and recreational exposures.  Exposures in sentinel animals may pose 
direct risk to humans, as in the case of fish contaminated with mercury.  In this case, 
monitoring of exposures and effects in these animals clearly provides a benefit to 
human health.  Rabinowitz et al. (2008) propose a concept of “shared risk” of humans 
and animals from hazards in the environment.  The authors identify scientific knowledge 
gaps, such as differential disease expression across species and interspecies 
differences in molecular and cellular pathways for gene-environment interactions, which 
hamper the use of animal data as resources for human health.  Two concepts 
suggested are “viewing a wider number of species as potential models for human 
environmentally induced disease, and incorporating animal sentinel data into clinical 
and public health decision making” (Rabinowitz et al., 2008).   
Wild animals living in a contaminated area can be useful models for exposure to 
environmental mixtures.  Field collection of animals exposed in situ offers an advantage 
over laboratory animal studies in that it is a more relevant exposure to environmental 
mixtures.  Animals collected from a contaminated site will be exposed to the same 
mixtures as a human on the site.  The exposures are low compared to laboratory 
studies and continue over time and throughout the lifespan, as is usually the case with 
human exposures.  Similar to human in situ exposures, wild animal in situ exposures 
usually occur through multiple routes and from multiple environmental media. 
Studies of wildlife exposed in situ have several limitations and disadvantages.  
The levels of exposure are rarely known and therefore must be estimated based on 
contaminant concentrations in environmental media and knowledge of animal 
behaviors.  It is often difficult to estimate how much time the organism spends in the 
contaminated environment.  Some species are migratory or have large home ranges; 
habitat and diet may vary seasonally.  Because the doses are lower than in laboratory 
studies, effects may be more difficult to measure.  The genetic variability may be far 
greater than in laboratory animals, and age and gender of collected wildlife may vary 
and be difficult to determine.  Because of these variations, large numbers of field 
specimens may be required to gain statistical power.  Capturing sufficient numbers of 
animals may be difficult, time-consuming and costly.  These many uncertainties are 
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similar to those found in human epidemiological studies.  Careful selection of the wildlife 
species to be studied can address some of these issues. 
Golden and Rattner (2003) have proposed four indices for ranking the utility of a 
terrestrial vertebrate species for biomonitoring of specific contaminants in a particular 
study area.  Exposure Potential estimates the likelihood that a species will be exposed 
to the contaminant through dermal, oral, or inhalation routes.  This varies with 
behaviors, such as foraging technique and habitat preference, which bring the organism 
into contact with contaminated environmental media.  Geographic Occurrence 
describes the range and seasonal occurrence of the species in the contaminated area.  
Ease of Collection is assessed by factors such as the  abundance, accessibility and 
ease of capture of the species.  Quantity of Existing Exposure and Effects Data refers to 
the amount of exposure and effects data available for a species relative to a particular 
contaminant or contaminant class.  Two additional indices describe the vulnerability of 
the species to a particular contaminant.  Sensitivity is the likelihood that an individual 
would sustain damage from exposure.  Resilience evaluates the ability of the population 
to recover from exposure to the contaminant and includes the effects of abundance and 
reproductive potential.  The authors used the proposed indices to rank a list of 25 
terrestrial vertebrate species for use in biomonitoring of important environment 
contaminant classes in the Atlantic Coast region (Golden and Rattner, 2003). 
Fox (2001) has reviewed potential wildlife sentinels for the Great Lakes-St. 
Lawrence Basin.  Animals studied include bald eagles, herring gulls, night herons, tree 
swallows, snapping turtles, mink, and beluga whales.  Health effects documented in 
these animals include reproductive impairment, developmental toxicity, genotoxicity, 
cancer, endocrine disorders, metabolic diseases and altered immune function.  In 
general, severity and frequency of health effects observed in wildlife increased in the 
most contaminated sites (Fox, 2001). 
Mink (Mustela vison) have been discussed as being appropriate sentinels for 
exposures to environmental contaminants (Basu et al., 2007).  Mink are abundant, 
widely distributed, and regularly trapped, and are at a high trophic level.  The authors 
noted that research groups partner with local trappers to gather biological samples from 
mink carcasses, providing a valuable way to obtain a steady supply of tissues (Basu et 
al., 2007).  Factors and mechanisms influencing the exposure of terrestrial vertebrates 
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to environmental contaminants have been reviewed by Smith et al. (2007); for 
mammals, these include habitat, diet and foraging habits. 
Pets are an interesting class of animals for use as sentinels because they share 
the human environment and have potential for similar exposures.  In one study (Backer 
et al., 2001), biomarkers of genotoxicity were measured in pet dogs from communities 
near Superfund sites contaminated with organochlorine pesticides and volatile organic 
chemicals.  Frequency of peripheral blood lymphocyte micronuclei was higher in dogs 
living near Superfund sites than in control animals from another community. 
Multigner et al. (2008) assessed parallel exposures of wild rats and humans.  
The study compared reproductive effects of pesticides in male workers in banana 
plantations and male wild rats living on the plantations.  Sperm characteristics and 
reproductive hormone levels were not significantly different between workers exposed 
to pesticides and unexposed workers.  However, rats captured on the banana plantation 
had lower testosterone levels and gonadosomatic indices than rats captured at a control 
site with low potential for pesticide exposure.  The authors concluded that wild rats may 
be more sensitive than humans to pesticide levels (Multigner et al., 2008). 
1.4.4.1 Biomarkers of Exposure 
Many human health and ecological risk assessments of contaminated sites 
estimate exposure based on concentrations of contaminants in environmental matrices 
such as soil.  Contaminant levels in environmental matrices are often heterogeneous, 
so a battery of environmental samples is collected in order to characterize an average 
concentration.  The contaminant concentrations are then used to calculate a daily 
exposure value (mass contaminant per body weight per day) using assumptions for 
mass of environmental matrix contacted, contact frequency and duration.  The amount 
of contaminant that actually crosses the body barriers and enters the body is estimated 
by the application of absorption factors.  This approach presents many challenges.  
Environmental matrix samples may not be representative of the whole site because of 
temporal and spatial variations in contaminant concentrations.  Matrix characteristics 
and contaminant physico-chemical properties may alter bioavailability.  Individual 
differences in toxicokinetics can cause variations in the dose of contaminant that 
reaches the target organ(s) where health effects occur. 
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An alternative or complementary approach is to measure biomarkers of 
exposure in exposed populations.  A biomarker of exposure is a biological indicator, at 
the molecular or cellular level, of exposure to an environmental contaminant.  
Biomarkers are useful tools for evaluating exposures of in situ populations.  Biomarkers 
of exposure encompass all exposure routes and indicate the internal dose, including the 
extent of contaminant absorption, distribution, metabolism and accumulation (Vainio, 
2001).  Biomarkers of exposure are effective for monitoring exposure of in situ 
populations to environmental mixtures because the biomarkers account for differences 
in bioavailability and toxicokinetics of mixture components, in addition to any biological 
or toxicological interactions between mixture components (Fossi, 1998). 
Biomarkers of exposure are also valuable as early warning signs that identify 
potentially harmful exposures before the effects are manifested at higher levels of 
organization (e.g., tissues, individuals, populations, or ecosystems).  For example, 
organophosphate pesticides cause damage to the central nervous system in birds 
which leads to changes in behavior and mortality.  Eventually, this can reduce the bird 
population by increased mortality or reproductive impairment.  The nervous system 
malfunctioning is caused by inhibition of a critical enzyme, acetylcholinesterase.  
Acetylcholinesterase activity is therefore a biomarker of exposure at the molecular level 
that can be used to identify a potentially harmful exposure of bird populations to 
organophosphate pesticides (Fossi, 1998). 
Exposure to genotoxic or carcinogenic contaminants such as PAHs can be 
detected by the use of DNA damage biomarkers.  Types of structural DNA damage 
include strand breaks, altered bases, abasic sites, dimerization of pyrimidine bases, 
mutations, and adducts.  DNA adducts have been used as biomarkers of PAH exposure 
in environmental toxicology studies of both humans (Kriek et al., 1998) and wildlife 
(Shugart, 2000).  DNA adduct levels have been evaluated by the 32P-postlabeling 
technique in a number of wildlife species, including muskrat, beluga whale, earthworm, 
mussel, catfish, trout, carp, and eel (Shugart, 2000).  A recent biomonitoring study 
reported increased DNA adduct levels in juvenile Coho salmon exposed to PAH-
contaminated freshwater lake sediments and confirmed the bioavailability of the 
contaminants (Barbee et al., 2008). 
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1.4.4.2 House Mouse 
The house mouse (Mus musculus) is a useful model species for environmental 
monitoring for several reasons.  House mice generally live commensally with humans, 
living in and obtaining food from human habitations, other buildings, or cultivated fields. 
Commensal house mouse populations are relatively stable and breeding continues 
throughout the year.  Commensal house mice have individual home ranges of less than 
10 square meters and rarely travel more than 50 feet from their established homes 
(Ballenger, 1999; Nowak, 1991).  Therefore, the exposures of house mice are localized 
and easier to characterize than a species with a larger home range.  House mice eating 
human food are exposed to the same food-borne contaminants as the humans.  Mice 
living in human dwellings are also exposed to the same contaminants in domestic water 
and indoor air.  House mice living outdoors in agricultural areas are exposed to 
agricultural chemicals and fuels used by humans. 
Laboratory-bred Mus musculus strains have been used extensively in medical, 
genetic, and toxicological research for decades.  A large body of knowledge has been 
amassed about their physiology, development, molecular biology and genome, their 
responses to challenge with environmental contaminants, and the variation of toxic 
endpoints between genetically distinct strains.  Comparison of commensal mice 
exposed in situ and laboratory mice exposed in controlled experiments can be a 
valuable way to link the laboratory and the field.  Similarly, comparison of biomarkers in 
humans and commensal mice living in the same area can be used to improve 
laboratory animal-to-human extrapolation of toxicity results. 
 
1.5 Objectives 
PAHs are widely distributed in the environment and are generated by many 
sources.  The potential of PAH-rich mixtures to cause health effects has been known for 
almost a century.  The toxicity of both individual PAHs and PAH mixtures has been 
documented in vitro, in laboratory animals and in wild animals exposed in situ.  
Occupational epidemiological studies have provided evidence of the health effects of 
PAH-rich mixtures in humans. 
Although PAH research has been ongoing for decades, there are still 
unanswered questions about the levels of PAHs in the environment, the potential for 
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human exposure to PAHs, the health effects associated with exposure, and how genetic 
susceptibility influences the internal dose and extent of health effects in individuals.  
The ultimate goal is to minimize health effects in exposed populations.  Accomplishing 
this goal requires an integrated approach, one which includes field studies and 
laboratory experiments, in vitro and in vivo systems, ranging from molecular-level to 
population-level.  The research documented in this dissertation includes chemical 
analysis of PAH concentrations in environmental media, laboratory-based studies of the 
role of genetic factors in PAH genotoxicity, and evaluation of biomarkers of exposure in 
ecological receptors. 
The first objective of this research was to quantify concentrations of PAHs in 
samples of settled house dust, which can be a source of human exposure to PAHs.  
Samples of floor dust were collected from communities in three locations: Sumgayit, 
Azerbaijan; Shanxi Province, China; and southern Texas, USA.  Organic material 
extracted from the dust samples was analyzed by gas chromatography/mass 
spectrometry to quantify thirty-six PAH analytes.  Total PAH surface loading and sample 
variability were evaluated and compared between the locations.  The PAH alkylation 
profile was also examined to determine the most likely sources of PAH contamination in 
the house dust samples. 
The second objective of this research was to investigate genetic factors 
influencing the formation of PAH-DNA adducts in sensitive cell culture models.  
Pregnane X receptor (PXR) is a nuclear receptor which regulates important 
metabolizing enzymes.  Metabolism of BaP can result in either detoxification or 
bioactivation to its genotoxic forms.  HepG2 is a human hepatocarcinoma cell line that 
is sensitive to PAHs and has low constitutive expression of PXR.  To evaluate the effect 
of PXR on BaP genotoxicity, DNA adduct formation was measured by 32P-postlabeling 
in BaP-treated parental HepG2 cells and human PXR-transfected HepG2 cells.  To 
further analyze PXR-regulated metabolic pathways, a panel of metabolizing genes was 
surveyed with real-time quantitative RT-PCR and the activity of the glutathione-S-
transferase family of enzymes was measured. 
The third objective of this research was to investigate DNA adduct levels in wild 
mice exposed to PAH mixtures in situ.  Wild mammals may be exposed to PAHs in soil 
both directly (dermal contact or ingestion) and indirectly through the food chain.  
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Evaluation of biomarkers of DNA damage, such as DNA adducts, may function as a 
measure of exposure to PAHs.  House mice (Mus musculus) were captured near 
homes in Sumgayit and Khizi, Azerbaijan which are part of an ongoing human health 
study.  Lung, liver, and kidney tissues were collected from the mice; DNA adduct levels 
in these tissues were measured by 32P-postlabeling.  Soil samples collected near the 
mouse capture sites were analyzed by gas chromatography/mass spectrometry for PAH 
content. 
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CHAPTER II 
A COMPARISON OF CONCENTRATIONS OF PAHS DETECTED IN 
DUST FROM VARIOUS REGIONS OF THE WORLD * 
 
2.1 Introduction 
Complex environmental mixtures may have a negative impact on human health.  
Information is needed to better quantify the composition and concentration of the 
components of complex mixtures in both the outdoor and indoor environment.  Humans 
may be exposed to complex mixtures that adhere to dust particles both outside and 
inside their homes.  Settled house dust can be a source of exposure through non-
dietary ingestion and dermal contact.  Children may have a higher potential for 
exposure to floor dust than adults because they spend much of their time on the floor 
and are likely to put in their mouths objects that may have picked up dust from the floor. 
House dust is a complex mixture of particles of both indoor and outdoor origin, 
including soil, biological matter, fibers and organic particles.  Environmental 
contaminants which have been detected in house dust include asbestos, several heavy 
metals, pesticides, phthalates, and polychlorinated biphenyls (Lewis et al., 1995; Lioy et 
al., 2002).  The contaminants extracted from settled house dust collected in Ottawa, 
Canada and Washington, USA were shown to be mutagenic in a cell culture bioassay 
(Maertens et al., 2004).  One of the major organic components of dust extracts is the 
polycyclic aromatic hydrocarbon (PAH) class of compounds.  PAHs are present in coal 
and petroleum products, and are formed during combustion of fossil fuels and biomass.  
In general, PAHs have low volatility and low aqueous solubility, and are mainly 
adsorbed to particles, such as house dust, rather than existing in the gaseous phase.  
PAHs in house dust may originate from both outdoor and indoor sources.  Typical 
indoor sources include combustion of fossil fuels and biomass for heating and cooking; 
burning of tobacco products, candles and incense; and cooking fumes.  Seven PAHs 
are classified as probable human carcinogens (B2) by USEPA.  Maertens et al.  (2004) 
______________________ 
* Reprinted with permission from “A comparison of concentrations of polycyclic aromatic compounds 
detected in dust samples from various regions of the world” by Naspinski C, Lingenfelter R, Cizmas L, 
Naufal Z, He LY, Islamzadeh A, Li Z, Li Z, McDonald T, and Donnelly KC. Environ Int 2008;34:988-993. 
doi:10.1016/j.envint.2008.03.008  Copyright [2008] by Elsevier Ltd. 
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estimated the excess lifetime cancer risk from non-dietary ingestion of PAH in settled 
house dust to exceed the acceptable range for pre-school children in homes with dust 
PAH loading at the 95th percentile.  Chuang et al. (1999) reported that ingestion of 
house dust and soil contributed 24% of the estimated daily dose of B2 PAH in a study of 
children in low-income households. 
The objective of this study was to evaluate the surface loading, variability and 
distribution of PAHs in residential floor dust.  Study homes were located in three areas 
which were assumed to have broadly divergent concentrations of chemicals in dust.  
These sites were selected because they are locations for on-going human health 
studies.  The first area, in south Texas, was described previously by Shalat et al. 
(2003).  The second site is near the city of Sumgayit in the Republic of Azerbaijan, a 
former Soviet Union republic.  The health risk of this population, described previously by 
Bickham et al. (2003), is of concern because they are living on contaminated land near 
an abandoned chemical manufacturing site.  The third site is in the Shanxi Province of 
northern China, an area where coal is a major fuel and the prevalence of neural-tube 
defects is high (Li et al., 2006). 
 
2.2 Materials and Methods 
2.2.1 Sampling Sites 
To obtain information regarding the variability of PAHs in several parts of the 
world, floor dust samples were collected from homes in three diverse geographic 
locations.  These included houses in Texas, USA, Sumgayit, Azerbaijan and Shanxi 
Province, China.  In Texas, 21 houses were sampled during a single collection period.  
In Azerbaijan, dust samples were collected from 19 different houses during two 
collection periods, one in spring (April and May) and one in autumn (September and 
October).  Two of these houses were sampled during both collection periods; thus, a 
total of 21 dust samples were collected in Azerbaijan.  Due to the distances between 
sampling locations, only 14 houses were sampled in China during two collection periods 
(spring and autumn). 
None of the homes in China or Azerbaijan had air conditioning.  Most homes in 
Texas were not air-conditioned.  In those with air conditioning (approximately 30%), 
most ran the system only during the night.  Thus, all of the homes in China and 
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Azerbaijan, and most of the homes in Texas were generally open to the environment, 
and dispersion of outdoor dust, during much of the year. 
House dust samples in Texas were collected from a rural community bordered 
by a large (several hundred hectare) agricultural field.  The climate is arid; there was no 
recorded rainfall during the month that the samples were collected.  Average annual 
rainfall for this area is approximately 80 mm.  Motor vehicle traffic is light and most 
homes have electricity and/or natural gas for heating and cooking.  Sources of PAHs in 
house dust are likely to be drift of airborne combustion products from distant densely-
populated areas, and occupant activities such as smoking tobacco, cooking, and using 
petroleum products. 
Dust samples in Azerbaijan were collected from a densely populated residential 
area in close proximity to an industrial complex in the city of Sumgayit.  Sumgayit is on 
the Absheron Peninsula in the Caspian Sea, north of the capital of Azerbaijan.  The city 
was built in the early 1950’s to serve as the major petrochemical production area for the 
Soviet Union.  The community where samples were collected is adjacent to a synthetic 
rubber plant.  Nearby industries include an electric power generating station, aluminum 
plant, chlor-alkali plant and pipe production facility.  The climate is windy, with a mild 
winter and hot, dry summer.  Annual rainfall averages 200-300 mm.  Electricity is the 
main power source for heating and cooking.  In addition to occupant activities, probable 
sources of PAHs in Azerbaijan house dust are track-in of PAH-contaminated soil and 
infiltration of airborne combustion products from the adjacent industrial facilities.  Many 
of the houses have been built from scrap that was removed from the adjacent rubber 
plant.  Thus, construction materials may be another source of PAHs in house dust. 
The third location for the collection of house dust was in Shanxi Province in 
China.  Dust samples were collected from houses that were located in small (population 
less than 25,000) rural villages.  Shanxi Province is a major coal producing area of 
China.  The climate is monsoonal continental, with long, cold, dry winters and mild wet 
summers.  Annual rainfall averages 400-600 mm.  Coal is used for heating and cooking, 
and power generation facilities in the region burn coal.  The major sources of PAHs in 
Shanxi house dust are therefore expected to be coal dust and coal combustion 
products.  As indicated with the other populations, occupant activities such as smoking 
may also contribute to the PAH load in house dust. 
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2.2.2. Dust Sample Collection 
One sample of settled dust was collected in each home on a filter cloth using a 
swipe method as described previously (Shalat et al., 2003).  This is an inexpensive 
method for collecting house dust that requires minimal equipment.  However, the 
method does not allow measurement of contaminant loading based on either mass of 
contaminant per mass of dust, or mass of contaminant in specific particle size of dust.  
Thus, in this study, contaminant loads are based on concentrations of contaminant per 
area sampled.  The samples were collected from a non-carpeted area of the floor as 
close as possible to the front door.  An area of approximately 1 m2 was marked off (or 
the largest possible area if less than 1 m2 of open floor surface was available).  A pre-
cleaned glass fiber filter cloth saturated with isopropanol was wiped over the marked 
area to remove floor dust.  The cloth was then wrapped in aluminum foil, placed inside a 
plastic bag and stored on ice prior to transport to the laboratory.  Upon arrival at the 
laboratory, samples were logged into the sample tracking record and stored at -4°C 
prior to extraction and analysis. 
2.2.3 Sample Extraction and Analysis 
To recover the organic material from the dust samples, each filter cloth was 
processed by pressurized fluid extraction in a Dionex ASE 200 Accelerated Solvent 
Extractor using a modified U.S. EPA Method 3545A (USEPA, 1998).  Extraction 
conditions were 2 static cycles for 5 minutes each at 1500 psi and 100°C with 100% 
HPLC-grade dichloromethane (EM Science, Gibbstown, NJ) solvent.  Extracts were 
dried for 20 minutes at 54°C in a Zymark TurboVap II evaporator, then redissolved in 1 
mL of dichloromethane.  An internal standard solution (Cambridge Isotope Laboratories, 
Andover, MA) of deuterated fluorene, pyrene and benzo[a]pyrene was added prior to 
analysis for quality control. 
The PAH analysis was conducted on a HP 5890 II Gas Chromatograph (GC) 
coupled to a HP 5972A Mass Spectrometer (MS) integrated with HP MS Chemstation, 
using a modified U.S. EPA SW-846 Method 8270C (USEPA, 1996).  The PAHs were 
separated using a HP-5MS, 0.25 µm film thickness, 60 m x 0.25 mm id, fused silica 
capillary column.  The split/splitless injector port was maintained at 300°C and the 
transfer line at 280°C.  The capillary column was initially at held 60°C for 2 minutes then 
ramped at 5°C/minute to 310°C and maintained at 310°C for 30 minutes.  The mass 
 55 
spectrometer was operated in the selected ion monitoring (SIM) mode and tuned with 
perfluorotributylamine (PFTBA) according to the manufacturer criteria.  The 
quantification of the PAHs is accomplished by comparison to reference compounds 
from a standard calibration solution.  Thirty-six PAH analytes were quantified, including 
alkylated PAHs (C1, C2, C3, and C4 derivatives of parent PAHs).  The practical 
quantitation limit for each analyte was 10 ng per mg extract. 
 
2.3 Results 
2.3.1 PAH Surface Loadings 
Dust samples were analyzed by GC/MS for 36 PAH analytes (Table 2-1).  These 
36 analytes include the 16 PAHs classified as priority pollutants by USEPA and two 
additional unsubstituted compounds, benzo[e]pyrene and perylene.  The other 18 
analytes are alkylated families, which represent PAH compounds with alkyl groups 
attached to the aromatic rings, specified by the number of carbons in the alkyl groups 
(C1, C2, etc.).  The sixteen USEPA priority pollutant PAHs, including a subset of seven 
probable human carcinogens (B2 carcinogens), and the alkyl-PAH analytes are listed in 
Table 2-1.  The number of fused 5-carbon and 6-carbon aromatic rings is listed for each 
analyte.  The 19 analytes with four or more rings are categorized as high molecular 
weight (HMW) PAHs. 
Surface loadings of PAHs were measured in mass of PAH per area of floor 
(µg/m2).  The floor loadings are summarized in Table 2-2 for each location.  Median 
floor loadings of total PAHs, HMW PAHs and B2 carcinogens were markedly different 
between the locations.  Median loading of total PAHs in floor dust collected from homes 
in China was 232 µg/m2 (Table 2-2).  In Azerbaijan, median total PAH concentration in 
dust was 6.1 µg/m2, while in Texas the median concentration was 1.34 µg/m2.  Minimum 
and maximum PAH concentrations in dust samples followed the same trend, with China 
more than an order of magnitude higher than Azerbaijan and Texas.  Note also that in 
China the minimum PAH concentration in house dust was greater than the maximum 
concentration in dust from Texas homes.  In many of the Texas samples, HMW PAHs 
were near detection limits and B2 carcinogens were undetectable.  In the dust samples 
from China, the minimum concentration of carcinogenic PAHs was greater than the 
maximum concentration of carcinogenic PAHs from either Texas or Azerbaijan. 
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Table 2-1 
Individual PAH analytes quantified in house dust extracts 
PAH Species a CAS RN Molecular Weight 
No. of 
Rings b 
Naphthalene a 91-20-3 128 2 
C1-Naphthalenes --- 142 2 
C2-Naphthalenes --- 156 2 
C3-Naphthalenes --- 170 2 
C4-Naphthalenes --- 184 2 
Acenaphthylene a 208-96-8 152 3 
Acenaphthene a 83-32-9 154 3 
Fluorene a 86-73-7 166 3 
C1-Fluorenes --- 180 3 
C2-Fluorenes --- 194 3 
C3-Fluorenes --- 208 3 
Anthracene a 120-12-7 178 3 
Phenanthrene a 85-01-8 178 3 
C1-Phenanthrene/Anthracenes --- 192 3 
C2-Phenanthrene/Anthracenes --- 206 3 
C3-Phenanthrene/Anthracenes --- 220 3 
C4-Phenanthrene/Anthracenes --- 234 3 
Fluoranthene a 206-44-0 202 4 
Pyrene a 129-00-0 202 4 
C1-Fluoranthenes/Pyrenes --- 216 4 
C2-Fluoranthenes/Pyrenes --- 230 4 
C3-Fluoranthenes/Pyrenes --- 244 4 
Benz[a]anthracene a 56-55-3 228 4 
Chrysene a 218-01-9 228 4 
C1-Chrysenes --- 242 4 
C2-Chrysenes --- 256 4 
C3-Chrysenes --- 270 4             
 C4-Chrysenes --- 284 4 
Benzo[b]fluoranthene a 205-99-2 252 5 
Benzo[k]fluoranthene a 205-82-2 252 5 
Benzo[e]pyrene 192-97-2 252 5 
Benzo[a]pyrene a 50-32-8 252 5 
Perylene 198-55-0 252 5 
Benzo[g,h,i]perylene 191-24-2 276 6 
Indeno[1,2,3-c,d]pyrene a 193-39-5 276 6 
Dibenzo[a,h]anthracene a 53-70-1 278 5 
a.  Analytes classified as priority pollutants by US EPA.  Analytes underlined 
are classified by US EPA as probable human (B2) carcinogens. 
b.  Low  Molecular Weight (LMW): 2-3 rings; High Molecular Weight (HMW): 4+. 
LMW 
HMW 
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Table 2-2   
Concentration of total and high molecular weight PAHs detected in 
dust samples collected from houses in Azerbaijan, China or Texas   
µg/m2 µg/m2 µg/m2
Total PAHs
Median 6.1 232 1.34
Min 0.7 42 0.24
Max 49.6 6720 35.3
CV (%) 112 183 208
High Molecular Weight PAHs
Median 2.9 162 0.11
Min 0.5 30 0.03
Max 20.0 4440 2.90
CV (%) 103 178 223
EPA B2 Carcinogen PAHs
Median 1.0 53 BDa
Min 0.2 12 BDa
Max 5.4 1620 0.27
CV (%) 94 177 254
Azerbaijan China Texas
n=21 n=14 n=21
 
a. BD = below detection limit 
 
 
Variability of floor loadings between samples within locations was high, with 
coefficients of variation (CV) of the mean ranging from 94% to 254% (Table 2-2).  The 
total PAH floor loading data are also presented in boxplots in Fig. 2-1 (note different 
scale for China).  The data distributions among the three locations are similarly right-
skewed, with the majority of samples clustered near the lower end, and a few high 
outliers.  This skewed distribution is typical for environmental contamination.  There was 
at least one house within each of the communities where PAH concentrations in dust 
were appreciably elevated in comparison to the other homes in the area.  The most 
likely explanation for these outliers is that the floor in these homes had not been 
cleaned as recently as in the other homes.  Information was not gathered during 
sampling to confirm this assumption. 
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NS
 
Fig. 2-1. Variability of floor surface total PAH loadings in each location. Total PAH 
loading represents mass of 36 PAH analytes per square meter of floor surface wiped.               
 outlier; * extreme outlier. NS: not-to-scale (China Y-axis scale 0-7000 µg/m2 vs. 
Texas/Azerbaijan 0-50 µg/m2). 
 
 
In China and Azerbaijan, samples were collected during the spring (April and 
May) and autumn (September and October) seasons.  Some seasonal differences in 
floor loadings are apparent when the data are separated by season (Fig. 2-2A).  In both 
China and Azerbaijan, concentrations of total PAHs in dust were appreciably higher in 
the spring than in the autumn.  However, in both countries, the percentages of the HMW 
PAHs were comparable between seasons (Fig. 2-2B).  Samples from Texas are not 
included in the figure because they were all collected in the same month. 
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A
B
 
Fig. 2-2. Seasonal variation in floor wipe samples from Azerbaijan and China. (A) Total 
PAH loading. (B) HMW PAH as % of total PAH. Azerbaijan: Autumn n=13, Spring n=8; 
two homes were sampled in both seasons. China: Autumn n=5, Spring n=9; none of the 
homes were repeated.  outlier; * extreme outlier. 
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2.3.2 PAH Profile 
The percentage of the various PAHs in dust provides information regarding 
possible sources of the chemicals, as well as the potential for the components of the 
mixture to cause adverse health problems.   The results presented in Fig. 2-3 compare 
the percentage of the various compounds in the dust extracts.   More than 90% of the 
extracts of dust samples collected in homes in Texas were the smaller (2- and 3-ring) 
PAHs.  These compounds are generally less toxic and more susceptible to degradation.  
In the extracts of dust from Azerbaijan and China, more than 50% of the PAHs were the 
larger (4-6 ring) compounds.   These compounds are both more persistent in the 
environment and include the compounds classified by the US EPA as B2 (probable) 
human carcinogens. 
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Fig. 2-3. PAH profile by number of aromatic rings in floor wipes from each location. The 
36 analytes were categorized by the number of fused aromatic rings in the represented 
compounds. Data presented are means ± standard error. 
 
 
The most abundant unsubstituted individual compounds were phenanthrene and 
fluoranthene in Azerbaijan, fluoranthene and chrysene in China, and naphthalene and 
phenanthrene in Texas (data not shown).  Including alkylated analytes, the most 
abundant PAH families were phenanthrenes/anthracenes in Azerbaijan, 
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fluoranthenes/pyrenes in China, and naphthalenes in Texas.  The percentage of total 
PAHs represented by the substituted PAHs varied appreciably among the three 
locations (Fig. 2-4).   In Texas, where low molecular weight PAHs predominated, alkyl 
substituted PAHs represented more than 50% of the concentration of the total PAHs.  In 
dust samples from China, where the high molecular weight PAHs were the predominant 
compounds, less than 35% of the total PAHs were alkyl-PAHs.  These results likely 
reflect the different source of PAHs in the three locations. 
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Fig. 2-4. Percentage of alkylated analytes. Data shown are means ± standard error. 
 
 
2.3.3 Source Classification 
The complex mixtures of PAHs associated with environmental pollution can be 
classified into two main categories depending on the process by which they are formed 
(Boehm, 2006).  "Petrogenic" PAHs originated from fossil fuels such as petroleum and 
coal.  These PAHs are formed over long periods of time at moderate temperatures.  
Petrogenic PAH mixtures are generally rich in the lower molecular weight PAHs (2 or 3 
rings).  "Pyrogenic" PAHs are present in the products of incomplete combustion of 
biomass and fossil fuels.  Pyrogenic PAHs are formed at high temperatures and are 
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generally enriched in HMW PAHs (4 to 6 rings) (Boehm, 2006).  The PAHs detected in 
dust samples from Texas appear to originate primarily from petrogenic sources.  
Concentrations of the low molecular weight PAHs detected in dust samples from Texas 
were generally more than 90% of the total PAH fraction, while the high molecular weight 
PAHs accounted for less than 10% of the total PAH fraction.   PAHs in the extracts of 
dust samples from Azerbaijan and China appeared to have originated primarily from 
pyrogenic sources.  The concentration of the 4-ring and larger PAHs for dust samples 
from both China and Azerbaijan was more than 50% the total PAH concentration (Fig. 
2-3).  It should also be noted (Fig. 2-2B), that the percentage of HMW PAHs was fairly 
constant between seasons in China and Azerbaijan.  This suggests that there was not a 
shift in the source of PAHs in dust between spring and autumn. 
Petrogenic and pyrogenic PAHs also differ in the degree of alkylation.  One 
characteristic of petrogenic PAHs is that the alkylated PAHs are more abundant than 
the parent PAH in each family (see Boehm (2006) for more information).  The high 
temperature processes that produce pyrogenic PAHs tend to destroy alkylated PAHs 
because they are more reactive; therefore, pyrogenic PAHs generally have much higher 
levels of parent compounds than alkylated compounds.  The alkylation profile of each 
sample was examined for the following groups: phenanthrenes + anthracenes (PA); 
floranthenes + pyrenes (FP); and benzanthracenes + chrysenes (BC).  Based on the 
alkylation profile, the samples were qualitatively classified as either petrogenic or 
pyrogenic.  The results are summarized in Table 2-3.  The profiles for the FP and BC 
groups were all pyrogenic (the BC group was not evaluated in the Texas samples 
because results were near or below detection limits).  In China, the PA group was 
heavily weighted towards pyrogenic, whereas in Texas and Azerbaijan, petrogenic and 
pyrogenic profiles were approximately equal in the PA groups. 
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Table 2-3 
Classification of major PAH sources in dust based on alkyl PAH profile   
Texasd Petrogenic % 52  (11/21) 0  (0/21)
Pyrogenic % 43  (9/21) 100  (21/21)
Azerd Petrogenic % 43  (9/21) 0  (0/21) 0  (0/21)
Pyrogenic % 52  (11/21) 100  (21/21) 100  (21/21)
China Petrogenic % 14  (2/14) 0  (0/14) 0  (0/14)
Pyrogenic % 86  (12/14) 100  (14/14) 100  (14/14)
----
PAa FPb BCc
----
 
a. PA = Phenanthrene + Anthracene + C1-, C2-, C3- and C4-Phen/Anth 
b. FP = Fluoranthene + Pyrene + C1-, C2-, C3-Fluor/Pyr 
c. BC = Benz[a]anthracene + Chrysene + C1-, C2-, C3- and C4-BaA/Chrys 
d. One sample each from Texas and Azerbaijan were not included in the PA group analysis 
because their PA group profiles did not clearly match a petrogenic or pyrogenic profile. 
 
 
 
2.4 Discussion 
The floor dust collection procedure used in this study is quick, inexpensive, 
easily portable, and requires no specialized equipment.  It is a convenient method for 
remote field studies in which the use of vacuum samplers, shipment of large samples, 
and repeat visits for timed-accumulation sampling are not feasible.  The method is 
semi-quantitative, yielding a measurement of contaminant surface loading (mass of 
contaminant per unit floor area), rather than contaminant concentration in dust.  
Although surface loading cannot be used directly in an exposure calculation, it is 
valuable for the hazard identification step of risk assessment.  The results of the 
analysis of floor dust samples can be used to identify the major organic and inorganic 
chemicals in homes; and, to provide qualitative information regarding potential sources 
of contaminants. 
The variability in PAH surface loading among the homes was high in all of the 
sampling locations (Table 2-2 and Fig. 2-1).  PAH surface loading consists of two 
components: the mass of dust per unit area, and the mass of PAH per mass of dust.  
The mass of dust per unit area depends on the characteristics of the surface (e.g., 
roughness), the frequency and efficacy of cleaning, and the deposition time (time since 
last cleaning).  In general, floors in the Texas homes were linoleum or tile, while in 
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Azerbaijan wood floors were most common, and in China all floors were brick.  Thus, 
dust accumulation in the rough surface encountered in China is likely to be highest.  
Weather and occupant activities also can impact accumulation of dust.  The mass of 
PAHs per mass of dust is to a large extent dependent on the characteristics of the 
sources and relative contributions of each source.  Although the results of the current 
study were highly variable, they clearly establish differences between the regions from 
which samples were collected.  PAH concentrations were lowest in the rural 
communities in Texas.   PAH concentrations were elevated in the homes in Azerbaijan 
that were located in close proximity to industrial facilities.  However, PAH 
concentrations in Texas and Azerbaijan were more than one order of magnitude lower 
than levels detected in the dust samples collected in China. 
Seasonal changes can cause variability in PAH surface loading.  Dust 
accumulation can be affected by ventilation and by the amount of dust in outdoor air.  
Also, the concentration of PAHs in dust can change depending on ventilation, home 
heating, etc.  PAH levels in the PM2.5 fraction of Beijing urban outdoor air was lowest in 
summer and highest in winter (He et al., 2006).  A study in the lower Rio Grande Valley 
of Texas revealed that PAH concentrations in house dust were lower in summer than in 
spring (Mukerjee et al., 1997).  In the current study, spring surface loadings were higher 
than autumn in both Azerbaijan and China (Fig. 2-2A). 
The distribution of PAH analytes in a sample is of significance because of the 
relative toxicity of the different PAHs.  In general, the heavier PAHs are more toxic.  All 
of the carcinogenic PAHs (cPAHs) contain 4 or more rings and are therefore in the 
HMW fraction.  The percentage of HMW PAHs was highest in China and lowest in 
Texas.  The HMW percentage did not seem to be seasonally distributed (Fig. 2-2B).  
The difference in PAH profiles among the three locations can also be seen in Fig. 2-3.  
Qualitatively, the relative carcinogenicity of the PAH mixtures in the house dust follows 
the trend China > Azerbaijan > Texas. 
The median total PAH surface loading in China was 40-fold higher than in 
Azerbaijan and more than 200-fold higher than in Texas.  Surface loadings of cPAHs 
followed the same trend, with median cPAH loading 50-fold higher in China than in 
Azerbaijan, and cPAHs below detection limits in most of the Texas samples.  These 
trends in total PAH surface loading, cPAH surface loading, and relative carcinogenicity 
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of the PAH mixtures suggest that the risk of health effects from exposure to PAHs in 
house dust is highest in the Chinese population, lowest in the Texas population, and 
intermediate in the Azeri population. 
Two main categories of PAH sources are combustion processes, which produce 
“pyrogenic” PAHs, and fossil fuels, which contain “petrogenic” PAHs.  In the current 
study, the degree of PAH alkylation was used to classify the PAHs in each sample as 
pyrogenic or petrogenic.  Phenanthrenes/anthracenes (PA) in China were mostly 
pyrogenic, while PA in Azerbaijan and Texas were approximately equally petrogenic 
and pyrogenic.  Sources of petrogenic PAHs in the study locations may include use and 
spills of petroleum products (e.g., motor fuels and oils, solvents, degreasers) in and 
near the home.  This is more likely in Texas, where many of the residents own motor 
vehicles, than in the other two locations, where most residents do not own motor 
vehicles.  Another likely source in China is dust from unburned coal.  A recent study of 
homes in Palermo, Italy, found that these lighter PAHs were generally petrogenic in 
kitchen samples and pyrogenic in samples from living rooms and bedrooms (Mannino 
and Orecchio, 2008). 
In the current study, the fluoranthenes/pyrenes and benzanthracenes/chrysenes 
groups had a pyrogenic alkylation profile in all the samples.  This is consistent with the 
Palermo study (Mannino and Orecchio, 2008), in which analysis indicated a combustion 
origin for the heavier PAHs in most indoor dust samples.  There are many potential 
sources of pyrogenic PAHs, including a) unvented or poorly vented combustion for 
heating and cooking; b) smoke from tobacco, candles and incense; c) cooking fumes; 
and d) infiltration of outdoor air contaminated with motor vehicle exhaust and industrial 
emissions.  It is difficult to distinguish these various sources by PAHs alone because 
the PAH profile formed during combustion often is more influenced by the 
characteristics of the combustion process (temperature, oxygen availability) than the 
combustion material (Boehm, 2006).  Identification of the various pyrogenic PAH 
sources likely requires that PAH analysis be combined with inorganic (e.g., metals) and 
other organic (e.g., nicotine) source-specific markers.  At this time, we are not aware of 
any published detailed characterization of pyrogenic PAH sources in house dust. 
In conclusion, the results of this study confirm that the wipe sample collection 
method provides a rapid and inexpensive means for obtaining qualitative information 
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regarding the distribution of PAHs in house dust.  The analysis of molecular weight 
distribution, coupled with information regarding alkylated compounds, allowed 
identification of the primary PAH source categories.  Information regarding the 
distribution of high and low molecular weight compounds, as well as carcinogenic 
PAHs, was used to develop a qualitative ranking of health risk due to exposure to dust.  
Variability among the samples confirmed the need to conduct multiple sampling rounds 
to more accurately capture the PAH contamination spectrum.  These results, coupled 
with ongoing investigation of appropriate PAH exposure biomarkers in humans, will 
guide future efforts to identify ways to reduce PAH exposures and ultimately to reduce 
risk. 
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CHAPTER III 
THE ROLE OF PREGNANE X RECEPTOR IN BAP-INDUCED DNA 
DAMAGE IN HEPG2 CELLS * 
 
3.1 Introduction 
Pregnane X receptor (PXR) is a nuclear receptor with broad specificity that is 
activated by structurally diverse lipophilic compounds.  It is expressed mainly in the 
liver, intestine and colon.  PXR plays an important role in pharmacokinetics of a broad 
spectrum of endogenous and xenobiotic compounds and appears to have evolved in 
part to protect organisms from toxic xenobiotics (Kliewer, 2003; Xie and Evans, 2001).  
PXR regulates metabolism and disposition of these compounds through coordinate 
regulation of the gene expression of phase I and II metabolizing enzymes and transport 
proteins (Maglich et al., 2002; Rosenfeld et al., 2003; Staudinger et al., 2003).  PXR 
protects the liver against toxic insult by both endogenous and xenobiotic compounds 
(Sonoda et al., 2005; Staudinger et al., 2001; Xie et al., 2001). 
Benzo[a]pyrene (BaP) is a common environmental contaminant found in air, 
water, soil, sediment and cooked foods.  BaP is a well-established animal carcinogen 
and a probable human carcinogen; human exposure to mixtures containing BaP has 
been linked with an increased risk of cancer (Boffetta et al., 1997; Mastrangelo et al., 
1996; Mumtaz et al., 1996; Sasco et al., 2004).  A critical step in the induction of cancer 
by BaP is bioactivation by phase I metabolizing enzymes, most notably by members of 
the cytochrome P450 (CYP) superfamily (Ramesh et al., 2004).  These electrophilic 
metabolites are capable of reacting with nucleophilic sites of DNA to form DNA adducts.  
The formation and persistence of carcinogen-DNA adducts have been shown to be 
critical events for the initiation of neoplasia in target cells.  However, phase I 
metabolism, when coupled with phase II conjugation and subsequent elimination by 
membrane-bound transporters, is also an important mechanism for detoxifying BaP.  
The toxicity of BaP in a particular organism, tissue, or cell type is determined by the 
balance among these competing metabolic pathways. 
______________________ 
*  Reprinted with permission from “Pregnane X receptor protects HepG2 cells from BaP-induced DNA 
damage” by Naspinski C, Gu X, Zhou GD, Mertens-Talcott SU, Donnelly KC, and Tian Y. 
Toxicol Sci 2008;104:67-73.  Copyright [2008] by Society of Toxicology. 
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In this study, the major goal was to test the hypothesis that PXR could modulate 
the genotoxicity of BaP.  A cell culture model was developed based on the well-
characterized human hepatoma cell line HepG2.  HepG2 cells possess many functional 
xenobiotic-metabolizing enzymes and are sensitive to PAHs (Knasmuller et al., 2004).  
However, constitutive expression of PXR is low or undetectable in HepG2 cells.  PXR 
expression was restored by stable transfection of human PXR (hPXR) expression 
plasmid.  The effect of PXR on BaP-induced DNA damage was investigated by 
comparison of DNA adduct formation in the parental cells and the hPXR-enhanced 
cells.  The results demonstrate that PXR decreases BaP genotoxicity in this cell model. 
The second goal of the study was to test the hypothesis that PXR attenuates 
BaP genotoxicity by regulation of metabolizing enzymes involved in detoxification 
pathways.  The gene expression of 20 BaP-metabolizing enzymes and 5 PXR-regulated 
transport proteins was measured by quantitative RT-PCR.  In addition, the total GST 
enzymatic activity was measured.  The results of the gene expression and enzyme 
activity experiments suggest that PXR reduces BaP genotoxicity by upregulating 
metabolizing enzymes that contribute to detoxification. 
 
3.2 Materials and Methods 
3.2.1 Materials 
The human HepG2 cell line was purchased from American Type Culture 
Collection (ATCC, Manassas, VA).  LipofectAMINE and oligonucleotides used as PCR 
primers were obtained from Invitrogen (Carlsbad, CA).  Dulbecco's modified Eagle's 
medium (DMEM) was from HyClone.  Fetal bovine serum was from Atlanta Biologicals 
(Lawrenceville, GA).  Plasmid DNA purification kits, rifampicin, nuclease P1, spleen 
phosphodiesterase, micrococcal endonuclease, and potato apyrase were from Sigma 
(St. Louis, MO).  Polynucleotide kinase was from USB Corp. (Cleveland, OH).  [-32P]-
ATP was from MP Biomedicals (Irvine, CA).  Benzo[a]pyrene (BaP) was obtained from 
Sigma and 5000x solutions were prepared in ACS-grade dimethyl sulfoxide (DMSO) 
from EMD Science (Gibbstown, NJ). 
3.2.2 Stable Transfection 
The expression vector for hPXR, p3XFlag-hPXR (Fig. 3-1A), was constructed as 
described previously (Gu et al., 2006).  The PCR primers were designed based on the 
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published hPXR sequence (Lehmann et al., 1998).  HepG2 cells were maintained in 
DMEM supplemented with 10% fetal bovine serum (FBS) and 1% antibiotic/antimycotic 
in 5% CO2 at 37°C.  For transfection, cells were seeded onto 6-well plates, and when 
cell density reached 50% confluency, transfected with PXR expression plasmid (0.5 
µg/well) by lipofection for five hours using LipofectAMINE according to manufacturer’s 
instructions.  After the transfected cells were cultured for two days, G418 (1 mg/ml) was 
added to the medium for an extended selection period.  The G418-resistant colonies 
were pooled and further selected with medium containing 400 µg/ml G418.  Surviving 
single colonies were cloned, expanded, and tested for PXR expression and ligand 
responsiveness. 
3.2.3 Cell Culture and Treatment 
Parental and hPXR-enhanced cells were cultured in DMEM supplemented with 
10% FBS and 1% antibiotic/antimycotic (100 units/ml penicillin G sodium, 100 µg/ml 
streptomycin sulfate and 0.25 µg/ml amphotericin B).  Cells were pretreated with 5 µM 
rifampicin (RIF) for 24 hours, then treated with BaP and collected after 24 h.  RIF and 
BaP controls consisted of an equivalent volume of DMSO. 
3.2.4 DNA Adduct Assay 
Cells were cultured in 150x25 mm culture dishes.  BaP was administered to the 
cells at three doses (0.5, 2, and 5 µM).  DNA was isolated from the cells using QIAGEN 
100/G Genomic-tips (QIAGEN, Valencia, CA) according to the manufacturer’s protocol. 
DNA adducts were quantified by the nuclease P1-enhanced 32P-postlabeling 
assay (Phillips and Arlt, 2007) using 6 µg DNA.  Multidirectional anion-exchange thin-
layer chromatography (conditions described previously in (Cizmas et al., 2004b)) was 
used to separate 32P-labeled DNA adducts on polyethyleneimine-cellulose sheets.  
Profile and radioactivity of DNA adducts from individual samples were determined by 
Instant Imager (PerkinElmer).  Student’s t-test was used to evaluate the effects of cell 
type and inducer treatment on adduct levels at each dose. 
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Fig. 3-1. Establishment of stable cell line expressing hPXR. (A) Schematic of hPXR 
expression plasmid 3XFlag-hPXR. (B) hPXR expression in HepG2 and stable 
transfected (PXR-G2) cells by RT-PCR. (C) CYP3A4 induction by RT-PCR in HepG2 
(PXR–) and PXR-G2 (PXR+) cells treated with 5 µM RIF (RIF+) or DMSO (RIF–). 
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3.2.5 Real-time Quantitative RT-PCR 
Cells were seeded in 12-well plates at 25% confluency and treated as described 
above.  BaP was administered at 5 µM (24 h).  Total RNA was isolated from the cells 
using Trizol Reagent (Invitrogen) according to the manufacturer’s instructions.  RNA 
from three replicate wells was pooled.  cDNA was synthesized by reverse transcription 
using Invitrogen's M-MLV Reverse Transcriptase according to the manufacturer's 
instructions.  PCR primers were designed based on published sequences and 
purchased from Invitrogen.  Real-time quantitative PCR was performed on a 7900HT 
Real Time PCR system from Applied Biosystems (Foster City, CA) using SYBR Green 
Master Mix (Applied Biosystems).  Results were normalized to -actin. 
3.2.6 GST Assay 
Cells were cultured as described above and treated with RIF (5 µM, 24 h) or 
DMSO.  The total activity of glutathione S-transferase (GST) was determined using the 
Glutathione S-Transferase Assay Kit (Cayman Chemicals, Ann Arbor, MI) following the 
manufacturer’s protocol.  The conjugation of 1-chloro-2,4-dinitrobenzene (CDNB) with 
reduced glutathione was measured spectrophotometrically (320 nm) and linear 
regression was performed to calculate a rate (slope).  Student’s t-test was used to 
evaluate the effects of cell type and inducer treatment on the slopes. 
 
3.3 Results 
3.3.1 Establishment of Stable Transfected Cell Line 
A modified HepG2 cell line, PXR-G2, was produced for this study using an 
hPXR expression plasmid, p3XFlag-hPXR (Fig. 3-1A).  Stable transfected colonies 
were selected with G418 and expanded.  The expression of transfected hPXR was 
confirmed by quantitative RT-PCR (Fig. 3-1B).  PXR mRNA level was 13-fold higher in 
the stable transfected PXR-G2 cells relative to the parental HepG2 cells.  The presence 
of transfected hPXR in the PXR-G2 cells increased the responsiveness of CYP3A4 to 
RIF (Fig. 3-1C).  Induction of CYP3A4 in response to RIF treatment (5 µM) was 
measured in both cell lines by real-time quantitative RT-PCR.  Response to RIF over 
DMSO control increased from 2-fold to 16-fold with the presence of transfected hPXR. 
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3.3.2 PXR Impact on BaP-induced DNA Adduct Formation 
The effect of hPXR expression on BaP-induced genotoxic effects in HepG2 and 
PXR-G2 cells was investigated.  DNA adduct formation was measured by 32P-
postlabeling in both cell lines, with or without RIF (5 µM) pretreatment, at three BaP 
doses (0.5, 2, and 5 µM).  HepG2 and PXR-G2 cells exhibited qualitatively similar 
profiles of BAP-induced DNA adducts.  The DNA adduct patterns with or without RIF in 
each cell line were also comparable (Fig. 3-2).  The major spot, Spot 3, was 
characterized in previous 32P-postlabeling analyses (Lu et al., 1986) as BaP-diol-
epoxide-N2-deoxyguanosine (BPDE-dG). 
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Fig. 3-2. Autoradiographic profiles of DNA adducts in parental HepG2 and hPXR-
enhanced (PXR-G2) cells treated with BaP (5 µM, 24h). Cells were pretreated with 
inducer RIF (RIF+) or DMSO control (RIF–) for 24 hours.  Screen-enhanced 
autoradiography was performed with Kodak XAR-5 film at -80°C for 1.5 h. 
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Fig. 3-3. Comparison of levels of DNA adducts in parental HepG2 cells (A) and hPXR-
enhanced (PXR-G2) cells (B) treated with BaP. Cells were pretreated with inducer RIF 
(RIF+) or DMSO control (RIF–) for 24 h, then treated with BaP (0.5, 2, 5 µM) for 24 h. 
Cells were collected and DNA adducts were detected by 32P-postlabeling assay. 
Adduct levels are means of triplicate treatments (except HepG2/RIF–/2 µM, which was 
duplicate) with S.E.M. error bars. Data are representative of two independent 
experiments.  * indicates statistically significant difference (p < 0.01) between RIF– and 
RIF+. 
 
 
Treatment with BaP, both with and without RIF pretreatment, resulted in 
formation of DNA adducts in a dose-dependent manner in both HepG2 and PXR-G2 
cells (Fig. 3-3).  4121 ± 248 adducts per 109 nucleotides were detected in HepG2 cells, 
whereas 2128 ± 134 adducts per 109 nucleotides were detected in PXR-G2 cells at the 
highest BaP dose (Fig. 3-4).  The presence of transfected hPXR had a statistically 
significant effect on adduct levels at 5 µM BaP both without inducer treatment  
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(p = 0.002) and with inducer treatment (p < 0.001).  Treatment with inducer significantly 
(p = 0.008) decreased adduct levels in PXR-G2 cells (37%), but decreased adducts 
levels in HepG2 cells by only 11%.  BPDE-dG (Spot 3) levels were significantly lower in 
PXR-G2 cells both without inducer pretreatment (p = 0.003) and with inducer (p < 
0.001) (data not shown).  These results indicate that PXR protects the cells from 
genotoxic effects of BaP. 
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Fig. 3-4. Effect of hPXR expression on BaP-DNA adduct formation. Parental HepG2 
(PXR–) and hPXR-enhanced HepG2 (PXR+) cells were treated with 5 µM BaP (24 h), 
without (RIF–) or with (RIF+) rifampicin pretreatment. Adduct levels are means of 
triplicate treatments with S.E.M. error bars. Data are representative of two independent 
experiments. 
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Table 3-1 
Effects of transfected PXR and BaP treatment on gene expression 
 
Change in mRNA Level a 
 
PXR-
HepG2 vs. 
HepG2 
HepG2 PXR-HepG2 
 DMSO BaP 5 µM 
vs. DMSO 
BaP 5 µM 
vs. DMSO 
Phase I Metabolizing Enzymes 
   
CYP1A1 2.5 350 98 
CYP1A2 8.8 120 130 
CYP1B1 ND b ND b ND b 
CYP2B6 3.6 2.7 1.1 
CYP3A4 1.2 2.0 2.3 
AKR1C2 16 3.5 0.7 
AKR1C3 3.0 1.5 1.1 
EPHX1 (mEH) 4.0 1.6 1.1 
EPHX2 (sEH) 0.6 0.6 0.9 
Phase II Conjugating Enzymes 
   
GSTA1 12 0.8 0.4 
GSTA2 16 1.0 0.6 
GSTA4 1.7 0.8 0.7 
GSTM1 140 1.6 1.2 
GSTP1 0.6 51 260 
GSTT1 ND b ND b ND b 
UGT1A6 200 3.2 0.8 
UGT2B10 0.8 0.8 0.8 
UGT2B15 ND b ND b ND b 
SULT1A1 2.3 1.2 1.5 
SULT1A3/4/5 3.3 2.6 1.3 
Transporters 
   
MDR1 (ABCB1) 0.8 1.3 1.0 
MRP1 (ABCC1) 1.2 1.2 0.7 
MRP2 (ABCC2) 4.0 1.2 0.4 
MRP3 (ABCC3) 3.7 1.6 0.8 
BCRP (ABCG2) 7.2 2.1 3.6 
 
a  Data are representative of three independent experiments. 
b  Gene expression not detectable. 
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3.3.3 PXR Regulation of Xenobiotic Metabolism and Elimination Genes 
The effects of BaP and PXR on expression of a panel of 25 genes were 
investigated by quantitative RT-PCR.  The products of these selected genes, which 
include metabolizing enzymes and drug transporters, are involved in xenobiotic 
pharmacokinetics.  Relative to parental HepG2 cells, stable PXR-HepG2 cells exhibited 
higher constitutive mRNA expression of many phase I and II xenobiotic enzymes 
including CYPs, GSTs and UGTs in the absence of BaP (Table 3-1).  Most notably, 
mRNA levels of CYP1A2 increased 8.8-fold, GSTM1 increased 140-fold and UGT1A6 
increased 200-fold.  In addition, mRNA levels of breast cancer resistance protein 
(BCRP), a transporter that excretes BaP-sulfate metabolites in colon cells (Ebert et al., 
2005), increased in PXR-HepG2 cells.  Upregulation of these genes in cells 
overexpressing PXR may reduce BaP toxicity by enhancing detoxification pathways. 
Following exposure to BaP, there was an increase in mRNA levels of some 
phase I and II enzymes in HepG2 cells, notably CYP1A1, CYP1A2, and GSTP1 (Table 
3-1).  A similar increase in mRNA levels of phase I and II enzymes was observed in the 
PXR-HepG2 cells following BaP exposure, although there was a notably higher 
increase in GSTP1 and a lower increase in CYP1A1 (Table 3-1). 
3.3.4 Effect of PXR on GST Enzymatic Activity 
The total activity of GST (cytosolic and microsomal) was assessed to determine 
the GST enzymatic levels.  The rate of CDNB conjugation, which is directly proportional 
to the GST activity, was measured in both cell lines, with or without RIF treatment (5 
µM, 24h).  The GST activity level was 8.23 ± 0.61 units per minute in HepG2 cells and 
34.0 ± 2.3 units per minute in PXR-G2 cells (Fig. 3-5), a 4-fold increase.  The presence 
of transfected hPXR had a statistically significant effect (p < 0.001) on GST activity both 
without rifampicin pretreatment and with rifampicin pretreatment.  Treatment with 
rifampicin had no effect on GST activity in HepG2 cells, but increased GST activity in 
PXR-G2 cells by 21% (p = 0.13).  These results, considered with the increased mRNA 
levels of GSTM1, GSTA1 and GSTA2, suggest that PXR increases the enzyme levels 
of GSTs in liver cells through transcriptional regulation of GST gene expression. 
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Fig. 3-5. Effect of hPXR expression on total GST enzymatic activity. Parental HepG2 
(PXR–) and hPXR-enhanced HepG2 (PXR+) cells were treated with DMSO (RIF–) or 5 
µM rifampicin(RIF+) for 24 h. Total GST enzymatic activity was determined by 
measuring the conjugation of 1-chloro-2,4-dinitrobenzene (CDNB) with reduced 
glutathione. Slopes of GST activity are means of triplicate treatments with S.E.M. error 
bars. 
 
 
3.4 Discussion 
PXR is a broad specificity, low affinity nuclear receptor that transcriptionally 
regulates many genes associated with xenobiotic metabolism and clearance, and 
therefore performs an important function for detoxification of xenobiotics (Kliewer, 
2003).  PXR is considered to be a xenosensor because of its ability to respond to many 
xenobiotics, including pharmaceuticals, dietary nutrients, and environmental 
contaminants.  Consistent with this protective role, PXR is mainly expressed in the liver, 
intestine and colon, which are sites of first-pass elimination.  Because PXR regulates a 
wide range of the genes expressed in the hepato-intestinal system, it may affect the 
pharmacokinetics/toxicokinetics of environmental contaminants.  The major goal of this 
study was to investigate the role of PXR in the genotoxicity of BaP, a well-known 
carcinogen and environmental contaminant.  Although PXR can be activated by many 
therapeutic drugs, naturally-occurring chemicals and environmental contaminants, its 
role as a sensor of BaP and effector on BaP detoxification has not been well 
understood. 
 78 
In the liver, PXR upregulates multiple phase I and phase II enzymes which 
metabolize BaP.  Metabolism is important in both the detoxification of BaP and its 
transformation to genotoxic metabolites.  For example, recent in vivo studies utilizing 
knockout mouse strains (Sagredo et al., 2006; Uno et al., 2004; Uno et al., 2006; Uno et 
al., 2001) indicate that CYP isoforms involved in phase I metabolism of BaP contribute 
to both the protective and potentiating pathways.  In the current model of BaP 
bioactivation, BaP is transformed to highly electrophilic dihydrodiol-epoxides (BPDEs), 
which then can form DNA adducts, through a series of steps mediated by phase I 
enzymes.  The formation of an epoxide is catalyzed by CYPs, followed by conversion to 
a dihydrodiol by epoxide hydrolases (EH), and further conversion by CYPs to BPDE 
(Ramesh et al., 2004).  Reactive ortho-quinones, which are also capable of forming 
DNA adducts, can be produced by oxidation of BaP-dihydrodiols by aldo-keto 
reductases (AKR) (Penning et al., 1999).  Phase I enzymes also contribute to 
detoxification by alternate reactions that form non-toxic or less toxic compounds, such 
as the conversion of BPDEs to tetraols by EH (Ramesh et al., 2004). 
Phase I metabolism adds functional groups which allow conjugation by phase II 
enzymes, a step that effectively detoxifies BaP by preventing further transformation to 
carcinogenic metabolites, and facilitates excretion from the cell.  In a discussion of the 
paradoxical effects of the CYP1 enzymes on BaP toxicity (Nebert et al., 2004), the 
authors suggest that detoxification may be enhanced in cells, such as hepatocytes and 
gastrointestinal epithelial cells, in which the CYP1s are tightly coupled to phase II 
enzymes. 
To analyze the role of PXR in BaP detoxification, we created a cell culture model 
using HepG2 cells, which lack PXR, and PXR-transfected HepG2 cells.  Levels of DNA 
adducts were significantly decreased by the expression of PXR and, in cells 
overexpressing PXR, by pretreatment with RIF.  Levels of BPDE-dG, the major adduct, 
were significantly lower in cells overexpressing PXR.  Although the other spots have not 
been identified, they seem to be BPDE-related adducts because they display a similar 
pattern to adducts detected in cells treated with pure BPDE (Li et al., 2001).  These 
results demonstrate that PXR protects the cells from the genotoxic effects of BaP, and 
suggest that PXR may reduce the formation of BPDE. 
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In our cell culture model, CYP1A2, GSTM1, UGT1A6, GSTA1, and GSTA2 were 
upregulated by PXR, independent of BaP (Table 3-1).  Consistent with the GST gene 
expression results, total GST activity was significantly increased by PXR, independent 
of BaP (Fig. 3-5).  GSTs catalyze the formation of glutathione conjugates of primary 
epoxides and BPDEs; UGTs catalyze the formation of glucuronide conjugates of 
dihydrodiols (Ramesh et al., 2004).  Following exposure to BaP, there was an increase 
in mRNAs of phase I and II enzymes in HepG2 cells (Table 3-1).  A similar increase in 
mRNAs of phase I and II enzymes was observed in PXR-HepG2 cells following BaP 
exposure, although there were notably higher increases in mRNAs of CYP1A2 and 
GSTP1 (Table 3-1).  As expected, the Ah receptor agonist BaP caused large increases 
in CYP1A1 mRNA in both HepG2 and PXR-HepG2 cells; interestingly, the increase was 
attenuated in PXR-transfected cells.  The mechanism for this attenuation is unclear and 
it is conceivable that a squelching mechanism may play a role where PXR competes 
with the Ah receptor for the common transcriptional co-regulators. 
mRNA levels of membrane-bound drug transporter BCRP, which has been 
shown to be regulated by PXR in mice (Anapolsky et al., 2006), increased 12-fold in the 
hPXR-enhanced cells.  BCRP actively excretes sulfate metabolites of BaP in Caco-2 
cells (Ebert et al., 2005) and has been shown to transport glutathione, glucuronide and 
sulfate conjugates of other compounds (Adachi et al., 2005; Suzuki et al., 2003).  BCRP 
may contribute to detoxification by removing BaP conjugates from the cell and thus 
decreasing bioavailability. 
Our results strongly suggest a mechanism in which PXR coordinately regulates 
phase I and II enzymes and transporters that are relevant for BaP metabolism and 
disposition, leading to BaP detoxification (Fig. 3-6).  Upregulated CYP increases initial 
BaP metabolism to epoxides.  A higher level of GST favors rapid conjugation of the 
epoxides rather than further metabolism to dihydrodiols by EH, which was not affected 
by PXR.  Higher levels of UGT increase conjugation of dihydrodiols.  Dihydrodiols are 
converted to BPDEs by upregulated CYP, but increased GST also favors rapid 
conjugation of BPDEs, reducing the amount available to bond to DNA.  Finally, 
upregulated BCRP enhances elimination of conjugated species from the cell. 
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Fig. 3-6. PXR-regulated detoxification of BaP: a possible metabolic mechanism. PXR 
upregulates CYP, GST, and UGT enzymes and the membrane-bound transporter 
BCRP. BaP enters the cell and is transformed through a cascade of phase 1 reactions.  
These metabolites are conjugated and transported out of the cell. These upregulated 
detoxification pathways decrease bioavailability, and therefore genotoxicity. 
 
 
In conclusion, this research demonstrates that PXR decreases the formation of 
BaP-induced adducts in an hPXR-enhanced liver cell line, indicating that PXR plays an 
important role in protecting these cells from genotoxicity induced by exposure to PAHs.  
The gene expression of several BaP-metabolizing phase I and phase II enzymes and 
one PXR-regulated drug transporter was increased in the hPXR-enhanced cells.  
Enzymatic activity of glutathione S-transferase, an important family of phase II 
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enzymes, was significantly higher in HepG2 cells overexpressing PXR.  Taken together, 
these data suggest that PXR may effectively decrease bioavailability of carcinogenic 
BaP metabolites by coordinately regulating a pathway of biphasic metabolism and 
excretion that reduces intracellular concentrations of BaP and pro-carcinogenic phase I 
metabolites.  These findings further our understanding of factors influencing the 
genotoxicity of BaP and can guide the design of in vivo studies that may help improve 
risk assessment of PAHs. 
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CHAPTER IV 
MEASUREMENT OF DNA ADDUCT LEVELS IN MICE EXPOSED TO 
PAH MIXTURES IN SITU 
 
4.1 Introduction 
4.1.1 Polycyclic Aromatic Hydrocarbons 
Polycyclic aromatic hydrocarbons (PAHs) are a common class of environmental 
contaminants which are present in coal and petroleum products and are formed during 
combustion of fossil fuels and biomass.  PAHs are introduced into the environment by 
both natural (e.g., forest fires) and anthropogenic (e.g., fossil fuel extraction and use) 
sources.  Most sources produce a complex mixture of hundreds of PAH compounds 
with many other hydrocarbons, making toxicity assessment difficult.  Decades of 
research have accumulated substantial evidence that occupational exposure to PAH-
rich mixtures such as coal tar and soot cause cancer in humans.  In addition, several 
individual PAH compounds are known animal carcinogens.  A commonly accepted 
mechanism of PAH carcinogenicity is induction of mutations by PAH-DNA adducts 
which are formed when electrophilic PAH metabolites covalently bond to DNA. 
4.1.2 Exposure Assessment and Biomarkers 
Many human health risk assessments of contaminated sites assume that the 
source of human exposure to the onsite contaminants is through intake of contaminated 
soil.  Soil contaminant concentrations are measured by chemical analysis of soil 
samples, and a daily human exposure value (mass contaminant per body weight per 
day) is calculated using assumptions for mass of soil contacted, contact frequency and 
duration.  The amount of contaminant that actually crosses the body barriers and enters 
the body is estimated by the application of absorption factors.  This approach presents 
many challenges.  Soil samples may not be representative of the whole site because of 
temporal and spatial variations in contaminant concentrations.  Soil characteristics and 
contaminant physico-chemical properties may alter bioavailability.  Individual 
differences in toxicokinetics can cause variations in the dose of contaminant that 
reaches the target organ where health effects occur.  An alternative or complementary 
approach is to measure biomarkers of exposure in exposed populations.  A biomarker 
of exposure is a biological indicator, at the molecular or cellular level, of exposure to an 
 83 
environmental contaminant.  Biomarkers of exposure encompass all exposure routes 
and indicate the internal dose, including the extent of contaminant absorption, 
distribution, and accumulation (Vainio, 2001).  Biomarkers are useful tools for 
evaluating exposures of in situ populations.  
Exposure to genotoxic contaminants such as PAHs can be detected by the use 
of DNA damage biomarkers.  Types of DNA damage include strand breaks, altered 
bases, mutations, and adducts.  DNA adducts have been used as biomarkers of PAH 
exposure in environmental toxicology studies of both humans (Kriek et al., 1998) and 
wildlife (Shugart, 2000). 
4.1.3 Study Location: Azerbaijan 
The sampling sites for this study are located in two regions of the Republic of 
Azerbaijan, a former Soviet Union republic.  Our research group is conducting a human 
health study in these regions.  The health risk of the human population in the Sumgayit 
area, described previously by Bickham et al. (2003), is of concern because they are 
living on contaminated land near chemical manufacturing sites.  A series of 
ecotoxicology studies have documented genotoxic effects in amphibians and reptiles 
captured from contaminated wetlands near Sumgayit (Matson et al., 2006; Matson et 
al., 2005a; Matson et al., 2005b; Swartz et al., 2003).  Genotoxic effects in wild 
mammals have not yet been measured. 
4.1.4 Study Objectives 
This is a preliminary study to determine if soil contamination and biomarkers of 
exposure in wild mammals are detectable in the study area.  Wild house mice (Mus 
musculus) were used as a model mammalian species for environmental monitoring.  
The objectives of this study were to: 1) quantify DNA adduct levels and variability in wild 
house mice, 2) quantify PAH levels in soil near the mouse capture areas, and 3) 
investigate the relationship between media contaminant level and biomarkers of 
exposure. 
 
4.2 Materials and Methods 
4.2.1 Study Sites 
House mice and soil samples were collected from four study sites in Azerbaijan 
during May, 2006.  Three sites (S-1, S-2 and S-3) are located in a densely populated 
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residential area in close proximity to an industrial complex in the city of Sumgayit.  
Sumgayit is on the Absheron Peninsula on the western shore of the Caspian Sea, and 
north of Baku, the capital of Azerbaijan.  The city was built in the early 1950’s to serve 
as a major petrochemical production area for the former Soviet Union.  The community 
where samples were collected is adjacent to a synthetic rubber plant.  Nearby industries 
include an electric power generating station, aluminum plant, chlor-alkali plant and pipe 
production facility.  Each study site is outside a home in the community. 
The fourth study site (K-1) is in a rural village approximately 70 km north of 
Sumgayit.  Samples were collected from a barn near one of the houses. 
4.2.2 Mouse Collection 
Mice were collected following procedures described in Animal Use Protocol # 
2004-161.  Sherman live traps were set at the study sites and left overnight.  Captured 
mice were collected the following day, sacrificed by cervical dislocation, and frozen 
whole.  Mice were shipped on ice to the laboratory.  Upon arrival at the laboratory, 
samples were logged into the sample tracking record and stored at -80°C.  The mice 
were later thawed and dissected to obtain skin, lung, liver, and kidney tissues.  The 
tissues were frozen and stored at -80°C prior to DNA isolation.  Four mice were 
collected in Sumgayit and five mice were collected in Khizi (Table 4-1).  Four mice were 
male and three mice were female (two of which were pregnant); sex of the other two 
mice could not be determined. 
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Table 4-1 
Description of wild house mice collected in Azerbaijan  
Mouse Area Site Description 
MS1 Sumgayit S-1 M 
MS2 Sumgayit S-2 Sex not determined 
MS3 Sumgayit S-3 Sex not determined 
MS4 Sumgayit S-3 F, pregnant 
MK1 Khizi K-1 F, pregnant 
MK2 Khizi K-1 M 
MK3 Khizi K-1 F 
MK4 Khizi K-1 M 
MK5 Khizi K-1 M 
 
 
4.2.3 DNA Isolation and Adduct Analysis 
DNA was isolated from the mouse tissues following the protocol by Gupta 
(1984).  Minced tissue (0.2 g to 0.5 g) was homogenized in a solution of 1% SDS/1mM 
EDTA, then incubated for 40 min at 38°C with 100 to 150 µL proteinase K (15 mg/mL) 
to digest proteins.  DNA/RNA was extracted from the digested sample into an aqueous 
phase using a three-step phenol/chloroform extraction: 1) phenol saturated with Tris-
HCL; 2) 1:1 mixture of saturated phenol and SEVAG (24:1 chloroform/isoamyl alcohol); 
and 3) SEVAG.  The DNA/RNA was precipitated and washed with ethanol, then 
dissolved in diluted SSC (1.5 mM NaCl, 150 µM Na citrate) and incubated with 15 µL 
RNase A (10 mg/mL) and 16.5 µL RNase T1 (5000 units/mL) for 40 min at 38°C to 
remove RNA.  DNA was again extracted from the digested sample into an aqueous 
phase by SEVAG, precipitated and washed with ethanol, then partially dried and 
redissolved in SSC to a concentration of approximately 2 µg/µL.  DNA concentration 
and purity were verified by UV/Vis spectrophotometer.  Isolated DNA was stored at -
80°C prior to DNA adduct labeling. 
DNA adducts were quantified by the nuclease P1-enhanced 32P-postlabeling 
assay (Phillips and Arlt, 2007; Reddy and Randerath, 1986), a four-part assay.  The first 
step was digestion, in which 10 µg DNA was incubated with a mixture of micrococcal 
nuclease (MN) and spleen phosphodiesterase (SPD), enzymes which cleave the DNA 
 86 
strands into deoxyribonucleoside 3’-monophosphates, both of normal nucleotides (Np) 
and adducted nucleotides (Xp).  Step 2, enrichment, enhanced the sensitivity of the 
assay by using nuclease P1 to cleave the phosphate group preferentially from the 
normal nucleotides (Np cleaved to N + p), leaving a solution of normal nucleotides (N), 
free phosphate groups (p), and adducted nucleoside 3’-monophosphates (Xp).  In the 
labeling reaction, Step 3, polynucleotide kinase (PNK) was used to radiolabel adducted 
nucleotides by transferring a radioactive phosphate group (*p) from [-32P]ATP to the 5’ 
end of the adducted nucleotides (*pXp).  Apyrase was used at the end of this step to 
remove excess [-32P]ATP.  The fourth step, resolution of adducts, was accomplished 
by multidirectional anion-exchange thin-layer chromatography (TLC) on 
polyethyleneimine-cellulose sheets.  TLC was done in three parts, which are 
summarized here; detailed chromatography conditions were described in (Reddy and 
Randerath, 1986).  The labeled sample was applied to the first sheet and D1 solvent 
(2.3 M NaH2PO4, pH 5.7) was used to remove impurities including most of the free 
phosphate (*p), minimizing background radioactivity.  The remaining labeled adducted 
nucleotides were cut out and transferred to 2D maps.  The 2D maps were developed 
vertically in D3 solvent (6.75 M urea, 3.82 M lithium formate, pH 3.35), washed, dried, 
and then developed horizontally in D4 solvent (0.72 M NaH2PO4, 0.45 M Tris-HCl, 7.65 
M Urea, pH 8.20) to separate the adducted nucleotides.  Radioactivities of the adduct 
spots from individual mice were determined by Instant Imager (PerkinElmer).  The 
detection limit of this assay is approximately 1 adducted nucleotide in one billion normal 
nucleotides. 
4.2.4 Soil Collection 
At each study site, three soil samples were collected near the areas from which 
mice were collected.  Approximately 250 g of the upper layer of soil was obtained for 
each sample.  The samples were placed in plastic bags and shipped on ice to the 
laboratory.  Upon arrival at the laboratory, samples were logged into the sample 
tracking record and stored at -4°C prior to extraction and analysis. 
4.2.5 Soil Extraction and Analysis 
Soil samples were air-dried to reduce moisture, ground, and sieved.  
Approximately 10 g of soil from each sample was extracted with HPLC-grade 
dichloromethane (EM Science, Gibbstown, NJ) in a Dionex ASE 200 Accelerated 
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Solvent Extractor.  Extracts were dried in a Zymark TurboVap II evaporator, then 
redissolved in 1 mL of dichloromethane.  An internal standard solution (Cambridge 
Isotope Laboratories, Andover, MA) of deuterated fluorene, pyrene and benzo[a]pyrene 
was added prior to analysis for quality control.  The PAH content of the prepared 
extracts was quantified using a modified SW-846 Method 8270C (USEPA, 1996) on an 
HP-5890 series II gas chromatograph (GC) with an HP5-MS capillary column (60m, 
0.25 mm ID) coupled to an HP-5972 mass spectrometer (MS) operated in selected ion 
monitoring (SIM) mode.  Thirty-six PAH analytes were quantified, including alkylated 
PAHs (C1, C2, C3, and C4 derivatives of parent PAHs).  The practical quantitation limit 
for each analyte was 10 µg per kg soil. 
 
4.3 Results 
4.3.1 Mouse DNA Adduct Levels 
A total of nine mice were dissected and their tissues isolated for DNA adduct 
labeling (Table 4-1).  Four mice were from sites in Sumgayit: one from S-1, one from S-
2, and two from S-3.  Five mice were from K-1 in Khizi.  Tissues isolated were skin, 
lung, liver, and kidney.  Each tissue was processed to extract DNA, and the DNA 
adducts were radio-labeled.  DNA adducts were detected in all liver, lung, and kidney 
samples; adducts were not detected in any skin samples. 
Lung, kidney, liver and total (sum of the three tissues) DNA adduct levels are 
presented in Table 4-2 for individual mice in both regions.  In the overall data set, tissue 
DNA adduct levels ranged from 5.8  to 34.1 adducts per billion nucleotides.  Total DNA 
adducts ranged from 32.1 to 85.0 adducts per billion nucleotides.  Variability of adduct 
levels in each tissue, quantified by relative standard error (data not shown), was less 
than 20%.  The maximum total adducts and maximum adducts in each tissue were 
detected in individuals from Khizi.  The minimum total, lung, and liver adduct levels 
were found in individuals from Sumgayit, whereas the minimum kidney adduct level was 
in a mouse from Khizi. 
Mouse DNA adduct levels grouped by region are presented both in Table 4-2 
and in Fig. 4-1 as means ± standard error (SE).  In the Khizi region, mean adduct levels 
in liver were highest, with similar lower levels in lung and kidney.  In the Sumgayit 
group, liver and kidney mean adduct levels were similar, and lung levels were lowest.  
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Mean liver adduct level in Khizi was significantly higher than in Sumgayit (p = 0.041).  
Lung and total adduct levels were also higher in Khizi, but the difference was not 
statistically significant.  Kidney adduct levels were similar in the two regions. 
 
Table 4-2 
DNA adduct levels detected in tissues of wild house mice (adducts / billion nucleotides) 
Region:
Mouse: MS1 MS2 MS3 MS4 Mean ±SE MK1 MK2 MK3 MK4 MK5 Mean ±SE
Lung 5.8 12.9 12.6 12.3 10.9 ± 1.7 13.0 26.6 17.8 7.0 7.2 14.3 ± 3.7
Kidney 14.6 10.8 24.1 8.4 14.5 ± 3.4 8.5 24.9 13.0 17.8 6.9 14.2 ± 3.3
Liver 27.2 8.8 10.6 11.4 14.5 ± 4.3 34.1 33.5 26.2 20.6 20.7 27.0 ± 2.9
Total 47.6 32.5 47.3 32.1 39.9 ± 4.4 55.7 85.0 57.0 45.4 34.7 55.6 ± 8.4
Sumgayit Khizi
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Fig. 4-1.  Adduct levels detected in mice from locations in Sumgayit and Khizi.  Data are 
presented as means ± SE.  * Liver adduct levels were significantly higher in Khizi mice 
(p = 0.041).  Sumgayit n=4; Khizi n=5. 
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Fig. 4-2.  Comparison of tissue adduct levels (adducts in 109 nucleotides) in individual 
mice.  X-Y plots of DNA adducts in A) lung versus liver; B) lung versus kidney; and C) 
liver versus kidney. 
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If the mice had one main source of PAH exposure, trends in DNA adduct levels 
between tissues would most likely be similar.  For example, if soil were the overriding 
source of PAH exposure, mice with higher exposure levels would be expected to have 
higher total adduct levels and higher levels in each tissue than mice with lower 
exposure levels.  For evaluation of trends between tissues, adduct data matched by 
mouse were graphed in X-Y plots of pairs of tissues (Fig. 4-2).  No obvious patterns 
were observed in these graphs.  For all three pairs of tissues, R-squared values 
obtained from linear regression were less than 0.25.  The data were also evaluated 
statistically by paired-sample t-test.  No correlation between tissues was found.  Adduct 
levels in one tissue were not predictive of adduct levels in another tissue from the same 
mouse. 
4.3.2 Soil PAH Levels 
Three soil samples from each of the four sites were analyzed by GC/MS for 36 
PAH analytes.  These analytes were described in detail in a previous study (Naspinski 
et al., 2008).  Eighteen of the analytes are individual, unsubstituted PAHs.  The other 18 
analytes are alkylated families, which represent PAH compounds with alkyl groups 
attached to the aromatic rings, specified by the number of carbons in the alkyl groups 
(C1, C2, etc.). 
PAH concentrations in all samples were at the low end of the detection limit of 
the analytical method.  In nine of the twelve samples, concentrations of each of the 36 
analytes were below the PQL of 10 µg/kg.  Detection frequencies of the 2-ring and 3-
ring PAHs were lower than those of the larger PAHs.  Naphthalene was detected in only 
2 of the 12 samples; alkylated naphthalenes were detected in 7 of the samples.  
Acenaphthene was detected in 3 samples and acenaphthylene was detected in 9 
samples.  Fluorene was detected in 5 samples; alkylated fluorenes were detected 7 
samples.  All other analytes were detected in at least 10 of the samples with the 
exception of the alkylated chrysenes (C2-chrysenes in 7 samples; C3- and C4-
chrysenes not detected in any sample).  The seven carcinogenic PAHs were detected 
in all 12 samples.  In both Sumgayit and Khizi, the most abundant unsubstituted tPAH 
analytes were carcinogens: benzo[b]fluoranthene and chrysene.  The most abundant 
PAH families (i.e., unsubstituted parent compounds plus their alkylated analytes) in both 
regions were fluoranthenes/pyrenes, followed by anthracenes/phenanthrenes. 
 91 
PAH levels found in the soil samples are summarized in Table 4-3.  The sum of 
all 36 analytes is reported as total PAH (tPAH).  A subset of seven PAHs considered by 
USEPA to be probable human (B2) carcinogens is reported as carcinogenic PAHs 
(cPAH).  In Table 4-3, the data are presented by individual site and also grouped by 
region.  Individual sample tPAH levels ranged from 15 µg/kg to 100 µg/kg and cPAH 
levels ranged from 7 µg/kg to 41 µg/kg.  Mean levels of tPAH were highest at S-1 and 
S-2, lower at S-3, and lowest at K-1.  A similar trend occurred in cPAHs.  Variability of 
tPAH levels at individual sites ranged from 7 to 18 µg/kg (standard error).  Variability of 
cPAH ranged from 2 to 8 µg/kg.  Mean cPAH levels as a percentage of tPAH ranged 
from 30% at S-3 to 42% at S-1.  When grouped by region, mean tPAH and cPAH levels 
were significantly (p < 0.05) higher in Sumgayit than in Khizi.  The fraction of cPAH was 
similar in the two regions: 36% in Sumgayit and 40% in Khizi. 
 
Table 4-3 
PAH levels in extracts of soil samples collected from sites in Azerbaijan   
Sumgayit Khizi
S-1 S-2 S-3 K-1 Overall Overall
n=3 n=3 n=3 n=3 n=9 n=3
Total PAHs, µg/kg
Mean 71 69 46 23 62 23*
SE 18 8 18 7 9 7
Min 37 57 20 15 20 15
Max 100 84 80 37 100 37
Carcinogenic PAHs, µg/kg
Mean 30 25 11 9 22 9*
SE 8 2 2 2 4 2
Min 14 21 8 7 8 7
Max 41 28 14 13 41 13
Carcinogenic PAHs, % of Total PAH
Mean 42 37 30 40 36 40
* denotes that Sumgayit mean is significantly higher (p < 0.05) than Khizi mean.
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4.4 Discussion 
The house mouse (Mus musculus) generally lives commensally with humans, 
living in and obtaining food from human habitations, other buildings, or cultivated fields.  
House mice dwelling in buildings such as houses, barns and granaries will often nest in 
a hidden spot near a source of food.  House mice living outdoors will nest in cracks in 
rocks or walls or build underground burrows.  Some individuals live outside during the 
summer but overwinter in buildings (Ballenger, 1999).  Commensal house mouse 
populations are relatively stable; breeding continues throughout the year and in suitable 
conditions a female produces 5 to 10 litters per year.  Sexual maturity is reached at 5 to 
7 weeks of age (Nowak, 1991).  Commensal house mice have individual home ranges 
of less than 10 square meters and rarely travel more than 50 feet from their established 
homes.  House mice in human habitations eat any accessible human food, but will also 
consume household materials including paste, glue and soap.  Outdoors, house mice 
eat many kinds of plant matter, including seeds, fleshy roots, leaves and stems.  They 
also consume insects such as beetle larvae, caterpillars and cockroaches, and carrion, 
when available (Ballenger, 1999; Nowak, 1991). 
Commensal house mice are a useful model species for environmental 
monitoring for several reasons.  House mice eating human food are exposed to the 
same food-borne contaminants as the humans.  Mice living in human dwellings are also 
exposed to the same contaminants in domestic water and indoor air.  House mice living 
outdoors in agricultural areas are exposed to agricultural chemicals and fuels used by 
humans.  In addition, laboratory-bred Mus musculus strains have been used extensively 
in medical, genetic, and toxicological research for decades.  A large body of knowledge 
has been amassed about their physiology.  Comparison of commensal mice exposed in 
situ and laboratory mice exposed in controlled experiments could be a valuable way to 
link the laboratory and the field. 
In this study, DNA adducts were detected by 32P-postlabeling assay in liver, lung 
and kidney of all collected wild house mice.  Liver adduct levels were significantly 
higher, and lung adduct levels were somewhat higher, in Khizi than in Sumgayit; kidney 
adduct levels were similar in the two regions.  The chromatographic properties of the 
detected spots were typical for bulky, nonpolar adducts such as those induced by PAHs 
(Randerath et al., 1997).  Further analysis to identify the chemical structure of specific 
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spots was not conducted, so positive identification of PAH-DNA adducts is not possible.  
Other environmental contaminants may form bulky nonpolar DNA adducts. 
In addition, the detected spots could be bulky covalent DNA modifications 
known as type I I-compounds, some of which have similar chromatographic properties 
to PAH-DNA adducts.  Type I I-compounds are derived from endogenous DNA-reactive 
intermediates of nutrient and oxygen metabolism and represent useful biomarkers in 
carcinogenesis and cancer prevention studies.  Type I I-compound levels vary 
depending on age, species, strain, tissue and gender and are also affected by diet as 
well as exposure to chemicals and hormones.  Numerous experiments have shown that 
many carcinogens and tumor promoters significantly reduce I-compound levels 
gradually during carcinogenesis and suggest that certain type I I-compounds may 
protect against carcinogenesis and age-related degenerative processes (Randerath et 
al., 1999).  Dietary restriction and food deprivation have been shown to increase levels 
of type I I-compounds in various rodent organs, especially in liver (Randerath et al., 
1999; Randerath et al., 1993; Zhou et al., 1999). 
House mouse exposure to contaminants in soil may be direct or indirect.  Direct 
dermal contact with soil occurs almost constantly in mice living outdoors.  Direct 
ingestion of soil occurs during grooming.  House mice are also indirectly exposed to 
contaminants in soil through their food sources: plants and insects that have taken up 
soil-borne contaminants during their life cycles. 
PAHs were detected in all soil samples collected from the Sumgayit and Khizi 
regions.  The mean concentrations of both tPAH and cPAH were statistically higher in 
Sumgayit than in Khizi.  However, the number of sampling sites was small (1 in Khizi, 3 
in Sumgayit), detection frequencies of some of the analytes were less than 50%, and 
the PAH concentrations were below the practical quantitation limit of the analytical 
method.  Care must be taken to not over interpret differences between small numbers.  
We can conclude that there is little or no difference in PAH levels in the two regions. 
A large body of soil PAH concentration data exists in the literature.  Comparison 
of concentrations between studies can be problematic because of the many different 
methods used for soil collection, extraction and analyte quantification.  However, order-
of-magnitude comparisons can be useful.  A common method for reporting “total PAH” 
concentrations is the sum of concentrations of sixteen unsubstituted PAHs classified as 
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priority pollutants by USEPA (16PAH).  Table 4-4 presents the 16PAH concentrations 
reported in several recent studies of soils in various European countries.  These soils 
include those in rural, urban, and industrial areas.  The Azerbaijan samples from the 
current study ranged from 10 to 68 µg/kg.  The most comparable concentrations were 
reported by Crnkovic et al. (2007) for rural soils near Belgrade, Serbia.  Rural soils in 
Switzerland (Bucheli et al., 2004) were somewhat higher.  Mean PAH levels measured 
in urban and industrial soils (Crnkovic et al., 2007; Maliszewska-Kordybach, 1996; 
Morillo et al., 2007; Saltiene et al., 2002) were an order-of-magnitude or more higher 
than those found in the current study.  Maliszewska-Kordybach (1996) has proposed 
classifying soils by 16PAH levels.  Soils which contain less than 200 µg/kg are classified 
as “not contaminated”.  The Azerbaijan samples clearly fall into this category.  All but 
two of the Azerbaijan samples also meet the Dutch government target of 20-50 µg/kg 
for unpolluted soil (Crnkovic et al., 2007). 
If the observed DNA adducts in the mice are PAH-DNA adducts, and soil is the 
main source of PAH exposure, we would expect adduct levels to be similar in the two 
regions because soil PAH levels are similar.  Kidney and lung adduct levels were 
similar.  Liver adducts, however, were significantly higher in mice from the Khizi site.  It 
is possible that the liver adduct levels are influenced by another environmental 
contaminant or by PAHs in another medium such as food or air.  PAHs in food have 
been determined to pose an appreciable health risk to the Azeri human population 
(Nwaneshiudu et al., 2007).  Food as a source of PAHs would affect liver adduct levels.  
However, we do not have information about differences in food sources or food PAH 
levels between Khizi and Sumgayit. 
Conversely, if the detected DNA modifications are type I I-compounds, the levels 
in Sumgayit could be decreased by exposure of the mice to non-PAH carcinogenic or 
tumor-promoting contaminants present in the area.  Levels of I-compounds in Khizi 
could also be increased if mice in Khizi were food-deprived compared to those in 
Sumgayit.  Type I I-compound levels may also be different because of different age and 
gender distributions between the two regions. 
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Table 4-4 
PAH concentrations in soils of several European countries 
Country Type Mean Min Max Reference
Azerbaijan mixed 32 10 68 current study
Serbia rural 18 1 62 Crnkovic et al ., 2007
Serbia urban 375 Crnkovic et al ., 2007
Switzerland rural 60 310 Bucheli et al ., 2004
Poland industrial 260 28 2450 Maliszewska-Kordybach, 1996
Slovenia urban 990 220 4490 Morillo et al ., 2007
Italy urban 1990 150 3410 Morillo et al ., 2007
Estonia urban 1020 250 4140 Saltiene et al ., 2002
Lithuania urban 650 400 1060 Saltiene et al ., 2002
a. Sum of concentrations of USEPA 16 priority pollutant PAHs, except for Morillo et al.  (2007),
    which excludes acenaphthylene.
16PAH, µg/kg a
 
 
 
In summary, we found that bulky DNA lesions were present in house mice from 
Sumgayit and Khizi; DNA lesion levels in liver were higher in Khizi than in Sumgayit.  
These DNA lesions may be a combination of environmentally-induced DNA adducts 
and naturally-occurring I-compounds.  The effects of environmental carcinogens on 
DNA lesion levels are complex because increased exposure tends to increase 
carcinogen-DNA adduct levels but tends to decrease type I I-compound levels.  
Therefore, no conclusions could be made about the relative risk posed by exposure of 
mice to environmental carcinogens in the two regions.  PAHs were present at 
background levels in soils from both Khizi and Sumgayit.  Based on the soil data, it 
appears that health risk posed to rodents by soil-borne PAHs is low in these two areas. 
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CHAPTER V 
SUMMARY 
 
PAHs are widely distributed in the environment and are generated by many 
sources.  The potential of PAH-rich mixtures to cause health effects has been known for 
almost a century.  The toxicity of both individual PAHs and PAH mixtures has been 
documented in vitro, in laboratory animals and in wild animals exposed in situ.  
Occupational studies have provided evidence of the health effects of PAH-rich mixtures 
in humans. 
Although PAH research has been ongoing for decades, there are still 
unanswered questions about the levels of PAHs in the environment, the potential for 
human exposure to PAHs, the health effects associated with exposure, and how genetic 
susceptibility influences the internal dose and extent of health effects in individuals.  
The ultimate goal is to minimize health effects in exposed populations.  Accomplishing 
this goal requires an integrated approach, one which includes field studies and 
laboratory experiments, in vitro and in vivo systems, ranging from molecular-level to 
population-level.  The research documented in this dissertation included chemical 
analysis of PAH concentrations in environmental media, laboratory-based studies of the 
role of genetic factors in PAH genotoxicity, and evaluation of biomarkers of exposure in 
ecological receptors. 
The first project of this research quantified concentrations of PAHs in samples of 
settled house dust.  Settled house dust can be a source of human exposure to toxic 
PAHs through non-dietary ingestion and dermal contact.  Information regarding the 
concentrations of various contaminants in house dust would be useful in estimating the 
risk associated with exposure to these compounds.  This study reported on the surface 
loading, variability and distribution of PAHs in settled house dust collected from homes 
in three locations:  Sumgayit, Azerbaijan; Shanxi Province, China; and southern Texas, 
United States.  Organic material extracted from the dust samples was analyzed by gas 
chromatography/mass spectrometry to quantify thirty-six PAH analytes.  Total PAH 
surface loading and sample variability were evaluated and compared between the 
locations.  The highest PAH floor surface loadings were observed in China, followed by 
Azerbaijan and Texas.  Median concentrations of high molecular weight (four ring and 
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larger) PAHs ranged from a low of 0.11 µg/m2 in Texas, to 2.9 µg/m2 in Azerbaijan and 
162 µg/m2 in China.  These trends in total surface loading and relative carcinogenicity 
indicate that the risk of health effects from exposure to PAHs in house dust is highest in 
the Chinese population and lowest in the Texas population.  As anticipated, variability 
among dust samples from different houses within the same region was high, with 
coefficients of variation greater than 100%.  Alkylated PAHs comprised 30% to 50% of 
the total mass of PAHs.  Based on a comparison of the composition of specific 
components, PAHs in China and Azerbaijan were determined to be derived mainly from 
combustion sources rather than from unburned fossil fuels such as petroleum. 
The results of the house dust study, coupled with ongoing investigation of 
appropriate PAH exposure biomarkers in humans, will guide future efforts to identify 
ways to reduce exposures in the study areas.  The substantially higher surface loadings 
in China suggest that this area would benefit most from further research.  Future work 
would benefit from use of a quantitative dust sampling method so that the results could 
be used in a human health risk assessment.  In addition, quantification of PAHs in 
samples of air and food would provide more information to evaluate inhalation and 
ingestion exposure pathways. 
The second project of this research investigated genetic factors influencing the 
formation of PAH-DNA adducts in sensitive cell culture models.  Pregnane X receptor 
(PXR) is a nuclear receptor that coordinately regulates transcriptional expression of 
both phase I and phase II metabolizing enzymes.  PXR plays an important role in the 
pharmacokinetics of a broad spectrum of endogenous and xenobiotic compounds and 
appears to have evolved in part to protect organisms from toxic xenobiotics.  
Metabolism of benzo[a]pyrene (BaP), a well-established carcinogen and ubiquitous 
environmental contaminant, can result in either detoxification or bioactivation to its 
genotoxic forms.  Therefore, PXR could modulate the genotoxicity of BaP by changing 
the balance of the metabolic pathways in favor of BaP detoxification.  To examine the 
role of PXR in BaP genotoxicity, BaP-DNA adduct formation was measured by 32P-
postlabeling in BaP-treated parental HepG2 cells and human PXR-transfected HepG2 
cells.  The presence of transfected PXR significantly reduced the level of adducts 
relative to parental cells by 50% to 65% (p<0.001), demonstrating that PXR protects 
liver cells from genotoxicity induced by exposure to BaP.  To analyze potential PXR-
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regulated detoxification pathways in liver cells, a panel of genes involved in phase I and 
phase II metabolism and excretion was surveyed with real-time quantitative RT-PCR.  
The mRNA levels of CYP1A2, GSTA1, GSTA2, GSTM1, UGT1A6, and BCRP (ABCG2) 
were significantly higher in cells overexpressing PXR, independent of exposure to BaP.  
In addition, the total GST enzymatic activity, which favors the metabolic detoxification of 
BaP, was significantly increased by the presence of PXR (p<0.001), independent of 
BaP exposure.  Taken together, these results suggest that PXR plays an important role 
in protection against DNA damage by PAHs such as BaP, and that these protective 
effects may be through a coordinated regulation of genes involved in xenobiotic 
metabolism. 
The role of PXR in protecting cells from environmental contaminants is an 
intriguing area for future research.  Metabolism studies which identify and quantify BaP 
metabolites generated by hPXR-enhanced cells, imaging studies which track the uptake 
and distribution of BaP in the cells, and investigation of cross-talk with other receptors 
and signalling pathways would further our understanding of the mechanism by which 
PXR reduces BaP-induced DNA damage.  In addition, studies in the recently-developed 
PXR-humanized mouse strain would shed light on the impact of PXR on in vivo 
toxicokinetics and genotoxicity of BaP. 
The third project of this research investigated DNA adduct levels in wild mice 
exposed to PAH mixtures in situ, quantified PAH levels in soil, and evaluated the link 
between mouse DNA adduct levels and potential PAH exposure.  Wild mammals may 
be exposed to PAHs in soil both directly (dermal contact or ingestion) and indirectly 
through the food chain.  Evaluation of biomarkers of DNA damage may function as a 
measure of exposure to PAHs.  House mice (Mus musculus) were captured near 
homes in Sumgayit and Khizi, Azerbaijan which are part of an ongoing human health 
study.  Lung, liver, kidney, and skin were collected from the mice; DNA adducts in these 
tissues were measured by 32P-postlabeling.  Soil samples collected near the mouse 
capture sites were analyzed by gas chromatography/mass spectrometry for PAH 
content.  DNA adducts were detected in all lung, liver, and kidney samples; adducts 
were not detected in any skin samples.  In the overall data set, tissue DNA adduct 
levels ranged from 5.8  to 34.1 adducts per billion nucleotides.  Mean liver adduct levels 
were significantly higher in Khizi than in Sumgayit.  Mean lung adduct levels and kidney 
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adduct levels were similar in the two regions.  Adduct levels in one tissue were not 
predictive of adduct levels in another tissue from the same mouse.  The DNA lesions 
detected may be a combination of environmentally-induced DNA adducts and naturally-
occurring I-compounds.  The effects of environmental carcinogens on DNA lesion levels 
are complex because increased exposure tends to increase carcinogen-DNA adduct 
levels but tends to decrease type I I-compound levels.  Therefore, no conclusions could 
be made about the relative risk posed by environmental carcinogens to mice in the two 
regions.  PAHs were present at background levels in soils from both Khizi and 
Sumgayit.  Based on the soil data, it appears that health risk posed to rodents by soil-
borne PAHs is low in these two areas. 
Further research is needed to better evaluate the impact of environmental 
genotoxins on mice in these two areas of Azerbaijan.  Samples of air and food could be 
collected and analyzed for PAH concentrations to quantify potential exposures from 
these sources.  The research would benefit from larger mouse sample groups to 
increase statistical power and provide more representation of various ages and both 
genders.  A measure of PAH body burden in the mice would provide more evidence of 
possible PAH exposure.  Finally, inclusion of laboratory mice as a control group in the 
PAH body burden and DNA adduct experiments would allow comparison to a relatively 
unexposed population. 
There is still much to be learned about the potential for exposure to PAHs, the 
health effects from exposure, and the most effective ways to characterize and mitigate 
health risk from environmental exposures.  Additional research in these areas, 
especially field sample collection from Azerbaijan and China, is resource-intensive and 
may be difficult in the current funding environment.  However, innovation and 
collaboration have been hallmarks of the field of environmental toxicology.  Application 
of innovative sampling and analysis techniques and strengthening of collaborative 
relationships with scientists in China and Azerbaijan will facilitate the future work in 
these areas. 
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